###begin article-title 0
###xml 68 73 <span type="species:ncbi:9606">human</span>
Protein-RNA and protein-protein interactions mediate association of human EST1A/SMG6 with telomerase
###end article-title 0
###begin p 1
###xml 0 16 0 16 <!--CREATIVE COMMONS-->
CREATIVE COMMONSThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 882 883 882 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 883 884 883 884 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 570 575 <span type="species:ncbi:9606">human</span>
The human EST1A/SMG6 polypeptide physically interacts with the chromosome end replication enzyme telomerase. In an attempt to better understand hEST1A function, we have started to dissect the molecular interactions between hEST1A and telomerase. Here, we demonstrate that the interaction between hEST1A and telomerase is mediated by protein-RNA and protein-protein contacts. We identify a domain within hEST1A that binds the telomerase RNA moiety hTR while full-length hEST1A establishes in addition RNase-resistant and hTR-independent protein-protein contacts with the human telomerase reverse transcriptase polypeptide (TERT). Conversely, within hTERT, we identify a hEST1A interaction domain, which comprises hTR-binding activity and RNA-independent hEST1A-binding activity. Purified, recombinant hEST1A binds the telomerase RNA moiety (hTR) with high affinity (apparent overall Kd = 25 nM) but low specificity. We propose that hEST1A assembles specifically with telomerase in the context of the hTR-hTERT ribonucleoprotein, through the high affinity of hEST1A for hTR and specific protein-protein contacts with hTERT.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 133 182 133 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae Ever Shorter Telomeres 1</italic>
###xml 211 233 211 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Caenorhabditis elegans</italic>
###xml 238 261 238 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila melanogaster</italic>
###xml 354 357 354 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1 B2 B3">1&#8211;3</xref>
###xml 579 580 579 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 581 582 581 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 994 1001 982 989 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1296 1297 1284 1285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 1511 1512 1499 1500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 1513 1514 1501 1502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 1712 1713 1700 1701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 1937 1950 1925 1938 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. cerevisiae</italic>
###xml 1955 1980 1943 1968 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schizosaccharomyces pombe</italic>
###xml 1986 1990 1974 1978 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EST1</italic>
###xml 2054 2061 2042 2049 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 2063 2064 2051 2052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 2065 2066 2053 2054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 2069 2082 2057 2070 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. cerevisiae</italic>
###xml 2214 2215 2202 2203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 133 157 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 211 233 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
###xml 238 261 <span type="species:ncbi:7227">Drosophila melanogaster</span>
###xml 1138 1143 <span type="species:ncbi:9606">human</span>
###xml 1930 1936 <span type="species:ncbi:4932">yeasts</span>
###xml 1937 1950 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 1955 1980 <span type="species:ncbi:4896">Schizosaccharomyces pombe</span>
###xml 2069 2082 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 2239 2244 <span type="species:ncbi:9606">human</span>
Human EST1A/SMG6 (below referred to as hEST1A), EST1B/SMG5 and EST1C/SMG7 were identified through their sequence similarity with the Saccharomyces cerevisiae Ever Shorter Telomeres 1 (Est1) gene product and the Caenorhabditis elegans and Drosophila melanogaster nonsense-mediated mRNA decay (NMD) factors CeSMG5, CeSMG6 and CeSMG7 and DmSMG5 and DmSMG6 (1-3). NMD leads to rapid decay of mRNAs that carry premature stop codons. Immunoprecipitation experiments using antibodies raised against hEST1A and hEST1B revealed association of these polypeptides with telomerase activity (1,2). We could not detect association between hEST1C/SMG7 and telomerase in co-immunoprecipitation experiments (Nele Hug and J. Lingner, unpublished data). Telomerase association is particularly evident for hEST1A, which appears to associate with approximately70% of active telomerase affinity purified from HeLa cell extracts. Consistent with a direct function of hEST1A at telomeres is its detection at telomeres in vivo by chromatin immunoprecipitation (Claus Azzalin and J. Lingner, manuscript submitted for publication). Over-expression of hEST1A in the human fibrosarcoma-derived cell line HT1080 induces telomere-telomere associations causing chromosome bridges during anaphase and a rapid apoptotic response (1). Telomeric fusions in hEST1A-over-expressing cells may stem from telomere uncapping followed by DNA break repair, reminiscent of the loss of function phenotype of the double strand telomere-binding protein TRF2 (4,5). Thus, we hypothesize that endogenous hEST1A is involved in modulating the telomere structure. Over-expression of full-length hEST1A in kidney 293T cells leads to progressive telomere shortening (2). This effect could be reversed by co-expression of telomerase reverse transcriptase (TERT), suggesting that the shortening depends on modulation of telomerase. Thus, hEST1A may also regulate telomere length. In the yeasts S. cerevisiae and Schizosaccharomyces pombe, the EST1 genes are required for telomerase-mediated telomere elongation in vivo (6,7). S. cerevisiae Est1p recruits telomerase to chromosome 3' ends through a direct physical interaction with the telomere end-binding protein Cdc13 (8). It is unknown if the human EST1-proteins play a similar essential role for telomerase activation at chromosome ends.
###end p 4
###begin p 5
###xml 256 257 256 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 401 403 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 404 406 404 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 431 433 431 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 712 713 712 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 714 716 714 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 19 24 <span type="species:ncbi:9606">human</span>
###xml 478 483 <span type="species:ncbi:9606">human</span>
###xml 831 837 <span type="species:ncbi:9606">humans</span>
The involvement of human EST1A-C/SMG5-7 in NMD has been substantiated in knock-down experiments, which leads to an increase in abundance of NMD-reporter constructs carrying premature stop codons, and of endogenous mRNAs that are regulated by this pathway (9). Worm SMG5-7 are involved in the PP2A-mediated dephosphorylation of UPF1, a highly conserved 5' to 3' helicase playing a central role in NMD (10,11) and genome stability [(12); (see below)]. SiRNA-mediated depletion of human EST1A-C/SMG5-7 leads to impairment of NMD and accumulation of hyperphosphorylated UPF1, over-expression of hEST1A/SMG6 promotes dephosphorylation of UPF1 and hEST1B/SMG5 and hEST1C/SMG7 are found in complexes with phospho-UPF1 (3,10). Thus, the role of SMG5-7 proteins in the phosphorylation cycle of UPF1 appear to be conserved between worms and humans.
###end p 5
###begin p 6
###xml 383 385 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 432 434 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 951 953 947 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 31 36 <span type="species:ncbi:9606">human</span>
###xml 251 256 <span type="species:ncbi:9606">human</span>
###xml 462 467 <span type="species:ncbi:9606">human</span>
The above studies suggest that human EST1-polypeptides may have dual functions in telomere maintenance and RNA surveillance pathways. Indeed, an intimate relation between genome and RNA surveillance pathways is also suggested by the findings that the human phosphoinositide 3-kinase-related protein kinase (PIKK) SMG1 is required for optimal activation of p53 upon genotoxic stress (13). Also UPF1 is required for genome stability (12). Depletion of UPF1 causes human cells to arrest early in S-phase inducing an ATR-dependent DNA damage response. A fraction of UPF1 associates with chromatin in S-phase and upon gamma-irradiation, supporting a direct role in genome stability. In contrast, downregulation of the NMD factor UPF2 does not interfere with cell cycle progression and DNA stability, supporting the notion that effects on genome stability are not due to a general loss in NMD and that only some NMD factors play a role in genome stability (14). Towards an attempt to understand the putative roles of hEST1A in telomere/genome stability and RNA surveillance pathways, we identify here functional domains of hEST1A that mediate the interaction with telomerase. We identify a high affinity RNA-binding domain in hEST1A and detect RNA-independent protein-protein interactions that mediate assembly with telomerase. We also identify a segment within the N-terminal part of hTERT, which enables association with hEST1A.
###end p 6
###begin title 7
MATERIALS AND METHODS
###end title 7
###begin title 8
Protein expression and purification
###end title 8
###begin p 9
###xml 223 235 223 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Homo sapiens</italic>
###xml 599 601 599 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 694 695 694 695 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 933 934 933 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 1901 1902 1877 1878 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 223 235 <span type="species:ncbi:9606">Homo sapiens</span>
A GST-tag encoding DNA fragment was amplified by PCR from the pGEX-6P1 vector (GE Healthcare) and subcloned in the pFastBac vector (Invitrogen). A DNA fragment encoding the complete open reading frame (1419 amino acids) of Homo sapiens EST1A (SMG6, KIAA0732) was subcloned in frame downstream of the GST-tag in the modified pFastBac vector. Baculoviruses were prepared following the manual of the Bac-to-Bac Baculovirus expression system (Invitrogen). Hi5 insect cells were transduced with baculoviruses at m.o.i. of 20. Forty-eight hour post-infection, nuclear extracts were prepared as described (15) with slight modifications. Infected Hi5 cell pellets harvested from 135 mm plates (1.5 x 107 cells before infection) were resuspended in 5.75 ml of cold buffer A (50 mM Tris-HCl pH 8.0, 100 mM KCl, 0.1 mM PMSF, 0.1 mM EDTA, 0.1 mM DTT, 0.3% NP40) and kept on ice for 15-20 min for cell lysis. After centrifugation for 5 min at 500g at 4degreesC, the nuclei containing pellet was washed three times with 1 ml buffer A, repeating in between the centrifugation step. For extraction, the washed nuclei were resuspended in 0.75 ml of cold buffer B (50 mM Tris-HCl pH 8.0, 400 mM NaCl, 1 mM EGTA, 1 mM EDTA, 1 mM DTT, 1 mM PMSF, protease cocktail inhibitor EDTA-free from Roche), transferred in a microfuge tube and shaken very gently for 30 min at 4degreesC. The mixture was centrifuged for 5 min with maximal velocity at 4degreesC. Tween 20 and glycerol were added to final concentrations of 0.2 and 10%, respectively, to the nuclear extract corresponding supernatant. 0.21 ml slurry of glutathione-Sepharose beads (GE Healthcare) were washed with cold 1x PBS and equilibrated with buffer B supplemented with 0.2% Tween 20 and 10% glycerol. The nuclear extract was added to these beads and incubated at 4degreesC for 1.5 h on a wheel. The flow through was collected upon centrifugation for 1 min at 500g at 4degreesC. The beads were washed three times with 1.5 ml of cold EB buffer (100 mM Tris-HCl pH 8.0, 400 mM NaCl, 10% glycerol, 0.2% Tween 20, 1 mM DTT, 1 mM EDTA and protease cocktail inhibitor EDTA-free). GST-hEST1A was eluted from the beads with 0.21 ml of cold GEB buffer (buffer EB containing 20 mM GSH) after incubation at 4degreesC for 45 min on a wheel. The recovered supernatant was applied to a small disposable filter column (Biorad) to remove the remaining beads. The elution step was repeated two more times for 15 min. Upon purification, the GST-hEST1A polypeptide was estimated to be more than 90% pure. As negative control, nuclear extracts of Hi5 cells that had been infected with baculoviruses containing only the GST transgene were prepared and purified following the same procedure.
###end p 9
###begin title 10
Plasmids
###end title 10
###begin p 11
###xml 174 176 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 209 211 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
DNA fragments encoding for the hTR deletion mutants downstream of a T7 promoter were generated by PCR (Pseudo and DeltaPseudo) or overlap extension PCR (DeltaCR45; see Ref. (16) for the method) using pT7hTER (17) as a template.
###end p 11
###begin p 12
###xml 626 628 626 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 375 378 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 428 432 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
hEST1A deletion mutants (1-855), (1-457), (1-237), (606-1419), (783-1419), (606-991) and (606-855) were generated by DNA restriction and ligation of DNA fragments into pcDNA6myc-HisC (Invitrogen) or by ligation into a modified phrGFP-N1 vector (Stratagene) in which a FLAG encoding sequence was used to replace the GFP sequence. In these vectors, expression is driven by the CMV promoter and polyadenylation is triggered by the SV40 poly(A) site. Mutant (243-533) was generated by PCR amplification of the respective hEST1A fragment and subcloning into pcDNA6myc-HisC. Mutant (243-412) was generated by overlap extension PCR (16) and subcloning into pcDNA6myc-HisC.
###end p 12
###begin p 13
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
hTERT deletion mutants (1-832), (1-656) and (1-446) were generated by DNA restriction and ligation in pcDNA6myc-HisC-hTERT (18). All the other hTERT-mutants were generated from pcDNA6myc-HisC-hTERT using a site-directed mutagenesis kit (Stratagene). Further details on plasmid constructions can be obtained upon request.
###end p 13
###begin title 14
RNA band shifts
###end title 14
###begin p 15
###xml 22 30 22 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 131 139 131 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 439 441 439 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 602 604 602 604 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 836 852 832 848 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 836 852 <span type="species:ncbi:562">Escherichia coli</span>
RNAs were transcribed in vitro following the instructions of the Ribomax large-scale RNA production system-T7 kit (Promega). After in vitro transcription, DNA templates were removed by DNase I digestion and the RNA samples were extracted with phenol:chloroform (1:1) and precipitated with ethanol. Analysis of the RNA samples by gel electrophoresis confirmed their correct length and intactness. Full-length hTR was prepared as described (17) and gel purified. Transcribed hTR was dephosphorylated at the 5' end with CIP (Roche) and extracted with phenol:chloroform (1:1). hTR was 5'-end labeled with [32P]-gamma-ATP using T4 polynucleotide kinase and unincorporated nucleotides were removed using mini quick spin RNA columns (Roche). Ribosomal RNA was gel purified from total RNA of HeLa cells prepared with the RNA easy kit (Qiagen). Escherichia coli tRNA was from Roche. RNA-protein complexes were separated on native 3.5% polyacrylamide/0.4% agarose gels that were run in 75 mM Tris-glycine buffer at 4degreesC (150 V for 30 min followed by 300 V for 3 h). The gels were pre-run for 1 h at 250 V.
###end p 15
###begin p 16
###xml 37 39 37 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kd</italic>
###xml 113 115 113 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 345 347 345 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
For the determination of the overall Kd of GST-hEST1A for hTR, GST-hEST1A (1-100 nM) was incubated with 1 nM 5' [32P]-labeled hTR (*hTR) in presence of a 250x excess of tRNA as a non-specific competitor in 70 mM Tris-HCl pH 8.0, 80 mM NaCl, 4 mM GSH, 1.2 mM EDTA, 1 mM DTT and 4% glycerol for 30 min at RT. Time-course experiments with 1 nM 5' [32P]-labeled hTR and 100 nM GST-hEST1A showed that the binding equilibrium was reached already after <1 min of incubation. For the competition experiments, competitor RNAs were added as indicated prior to addition of hEST1A. Prior to loading on the gel, 1 microl of 20% Ficoll was added. Competition experiments were quantified from three independent reactions.
###end p 16
###begin title 17
Pull-down experiments of telomerase and quantification of the activity
###end title 17
###begin p 18
###xml 78 80 74 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 158 160 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 640 648 608 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 744 746 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 749 758 717 726 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1.</label>
###xml 841 849 809 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 877 878 845 846 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1215 1216 1183 1184 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1275 1276 1243 1244 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1462 1470 1430 1438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1569 1577 1537 1545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 758 1644 726 1610 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="19">Expression and purification of recombinant GST&#8211;hEST1A protein and interaction with <italic>in vitro</italic> reconstituted telomerase. (<bold>A</bold>) SDS&#8211;PAGE and Coomassie blue staining of GST&#8211;hEST1A fractions derived from Hi5 insect cells. Lane 1: MW: Molecular weight markers. Lane 2: L: GST&#8211;hEST1A expressing Hi5 nuclear extract. Lane 3: FT: flow through of GSH-beads. Lanes 4&#8211;6: E1, E2 and E3: first, second and third eluates, Lanes 7&#8211;10: BSA dilutions. GST&#8211;hEST1A is indicated. (<bold>B</bold>) Western blots with anti-GST and anti-hEST1A antibodies. (<bold>C</bold>) Relative TRAP activity (%) pulled down with GSH-beads upon incubation of 50 nM GST (white rectangles) or 50 nM GST&#8211;hEST1A (fraction E1; black rectangles) with telomerase reconstituted <italic>in vitro</italic> in insect cell lysates (Baculovirus) or in RRL. Interaction of GST&#8211;hEST1A and GST with telomerase <italic>in vitro</italic>. Bars represent the means &#177; SD of three independent experiments.</p>
###xml 758 1644 726 1610 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="19">Expression and purification of recombinant GST&#8211;hEST1A protein and interaction with <italic>in vitro</italic> reconstituted telomerase. (<bold>A</bold>) SDS&#8211;PAGE and Coomassie blue staining of GST&#8211;hEST1A fractions derived from Hi5 insect cells. Lane 1: MW: Molecular weight markers. Lane 2: L: GST&#8211;hEST1A expressing Hi5 nuclear extract. Lane 3: FT: flow through of GSH-beads. Lanes 4&#8211;6: E1, E2 and E3: first, second and third eluates, Lanes 7&#8211;10: BSA dilutions. GST&#8211;hEST1A is indicated. (<bold>B</bold>) Western blots with anti-GST and anti-hEST1A antibodies. (<bold>C</bold>) Relative TRAP activity (%) pulled down with GSH-beads upon incubation of 50 nM GST (white rectangles) or 50 nM GST&#8211;hEST1A (fraction E1; black rectangles) with telomerase reconstituted <italic>in vitro</italic> in insect cell lysates (Baculovirus) or in RRL. Interaction of GST&#8211;hEST1A and GST with telomerase <italic>in vitro</italic>. Bars represent the means &#177; SD of three independent experiments.</p></caption>
###xml 1644 1644 1610 1610 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm724f1"/>
###xml 749 1644 717 1610 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F1" position="float"><label>Figure 1.</label><caption><p textid="19">Expression and purification of recombinant GST&#8211;hEST1A protein and interaction with <italic>in vitro</italic> reconstituted telomerase. (<bold>A</bold>) SDS&#8211;PAGE and Coomassie blue staining of GST&#8211;hEST1A fractions derived from Hi5 insect cells. Lane 1: MW: Molecular weight markers. Lane 2: L: GST&#8211;hEST1A expressing Hi5 nuclear extract. Lane 3: FT: flow through of GSH-beads. Lanes 4&#8211;6: E1, E2 and E3: first, second and third eluates, Lanes 7&#8211;10: BSA dilutions. GST&#8211;hEST1A is indicated. (<bold>B</bold>) Western blots with anti-GST and anti-hEST1A antibodies. (<bold>C</bold>) Relative TRAP activity (%) pulled down with GSH-beads upon incubation of 50 nM GST (white rectangles) or 50 nM GST&#8211;hEST1A (fraction E1; black rectangles) with telomerase reconstituted <italic>in vitro</italic> in insect cell lysates (Baculovirus) or in RRL. Interaction of GST&#8211;hEST1A and GST with telomerase <italic>in vitro</italic>. Bars represent the means &#177; SD of three independent experiments.</p></caption><graphic xlink:href="gkm724f1"/></fig>
###xml 88 94 <span type="species:ncbi:9986">rabbit</span>
1 microl of reconstituted and affinity purified telomerase from insect cells (17) or in rabbit reticulocyte lysates (RRL) (Promega) reconstituted telomerase (19) was incubated with 0.5 pmol of purified GST-hEST1A or GST for 1 h at 4degreesC in 10 microl final volume of 20 mM HEPES pH 7.9, 100 mM KCl, 1 mM DTT, 10% glycerol and 0.2% Tween 20. 9 microl of this mixture was added to 36 microl of 30% slurry of GSH-Sepharose beads (GE Healthcare) in IP buffer (20 mM HEPES pH 7.9, 100 mM KCl, 1 mM DTT, 10% glycerol, 0.2% Tween 20) and incubated 1 h at 4degreesC on a wheel. The beads were washed three times with 150 microl of IP buffer. In Figure 1, telomerase activity was measured by TRAP using quantitative PCR and the light cycler (Roche) (18). Figure 1.Expression and purification of recombinant GST-hEST1A protein and interaction with in vitro reconstituted telomerase. (A) SDS-PAGE and Coomassie blue staining of GST-hEST1A fractions derived from Hi5 insect cells. Lane 1: MW: Molecular weight markers. Lane 2: L: GST-hEST1A expressing Hi5 nuclear extract. Lane 3: FT: flow through of GSH-beads. Lanes 4-6: E1, E2 and E3: first, second and third eluates, Lanes 7-10: BSA dilutions. GST-hEST1A is indicated. (B) Western blots with anti-GST and anti-hEST1A antibodies. (C) Relative TRAP activity (%) pulled down with GSH-beads upon incubation of 50 nM GST (white rectangles) or 50 nM GST-hEST1A (fraction E1; black rectangles) with telomerase reconstituted in vitro in insect cell lysates (Baculovirus) or in RRL. Interaction of GST-hEST1A and GST with telomerase in vitro. Bars represent the means +/- SD of three independent experiments.
###end p 18
###begin p 19
###xml 83 91 83 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 119 120 119 120 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 457 458 457 458 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 517 518 517 518 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 704 712 704 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 811 819 811 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Expression and purification of recombinant GST-hEST1A protein and interaction with in vitro reconstituted telomerase. (A) SDS-PAGE and Coomassie blue staining of GST-hEST1A fractions derived from Hi5 insect cells. Lane 1: MW: Molecular weight markers. Lane 2: L: GST-hEST1A expressing Hi5 nuclear extract. Lane 3: FT: flow through of GSH-beads. Lanes 4-6: E1, E2 and E3: first, second and third eluates, Lanes 7-10: BSA dilutions. GST-hEST1A is indicated. (B) Western blots with anti-GST and anti-hEST1A antibodies. (C) Relative TRAP activity (%) pulled down with GSH-beads upon incubation of 50 nM GST (white rectangles) or 50 nM GST-hEST1A (fraction E1; black rectangles) with telomerase reconstituted in vitro in insect cell lysates (Baculovirus) or in RRL. Interaction of GST-hEST1A and GST with telomerase in vitro. Bars represent the means +/- SD of three independent experiments.
###end p 19
###begin title 20
###xml 16 21 <span type="species:ncbi:9606">human</span>
Transfection of human cell lines and immunoprecipitation
###end title 20
###begin p 21
###xml 605 606 587 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 998 999 946 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
The 293T cells were transfected with 4 microg of total plasmid DNA per well of a 6-well plate using Lipofectamine 2000 (Invitrogen). WI38-VA13 cells were transfected in 10 cm dishes with Lipofectamine 2000 (Invitrogen) as recommended by the manufacturer. Twenty-four hours post-transfection plasmid-containing cells were selected with 4 microg/ml blasticidin for 48 h. Whole cell extracts were prepared by resuspending cells in 600 microl of IPII buffer (50 mM HEPES pH 7.5, 140 mM NaCl, 0.5% TritonX-100), incubating the cell suspension for 30 min at 4degreesC and centrifugating at 13 000 r.p.m. (16 100g) for 10 min. The supernatant was pre-cleared for 1 h at 4degreesC with protein A beads (GE Healthcare) and then incubated with 1 microg/ml of either alpha-Myc (9B11 from NEB) or alpha-FLAG (M2 from Sigma) antibodies for 1 h at 4degreesC. 20 microl of a 50% slurry of protein A beads was added and incubated over-night at 4degreesC. Beads were recovered by spinning 1 min at 6500 r.p.m. (4000g) and washed five times in the IPII buffer. Samples were loaded on 4-20% gradient Tris-HCl PAGE duramide gels (Cambrex). After semi dry transfer and western blotting, the signals were measured using the ChemiGlow (Wytec) substrate on a FluorChemtrade mark 8900 machine (Alpha Innotech).
###end p 21
###begin title 22
###xml 23 29 <span type="species:ncbi:9986">rabbit</span>
Immunoprecipitation in rabbit reticulocyte lysate
###end title 22
###begin p 23
###xml 51 59 51 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 91 93 91 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 285 287 282 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 710 717 684 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 1095 1097 1051 1053 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1184 1191 1133 1140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 1528 1529 1458 1459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 1746 1747 1669 1670 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 1983 1985 1905 1907 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 2010 2012 1932 1934 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 2077 2079 1999 2001 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 2123 2125 2045 2047 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 2176 2178 2098 2100 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 710 717 <span type="species:ncbi:562">E. coli</span>
###xml 1184 1191 <span type="species:ncbi:562">E. coli</span>
Myc-hTERT fragments and Flag-hEST1A fragments were in vitro translated in the presence of [35S]-methionine in RRL following the instructions of TnT quick-coupled transcription/translation system (Promega). A total of 110 mul of RRL-mix containing 88 mul of TNT T7 master mix, 4.4 mul [35S]-methionine (1000 Ci/mmol, 10 mCi/ml) and 440 ng plasmid DNA was incubated for 1.5 h at 30degreesC. Protein A beads were first washed with 1x PBS and then with IPIII buffer [20 mM HEPES pH 7.5, 150 mM NaCl, 10% glycerol, 0.2% Tween 20, 0.4 U/mul RNAguardtrade mark (GE Healthcare) and protease cocktail inhibitor (EDTA-free, Roche)] and then blocked for 1 h at 4degreesC in 1 ml of IPIII buffer supplemented with 100 mug E. coli tRNA and 500 mug BSA (NEB). The pre-blocked beads were resuspended in IPIII buffer to give a 50% slurry. For each immunoprecipitation, 1 mug of either alpha-Myc (9B11 from NEB) or alpha-FLAG (M2 from Sigma) antibodies were pre-incubated for 2.5 h at 4degreesC with 20 mul of 50% slurry of protein A beads (GE Healthcare) in IPIII buffer. For hTR-binding experiments, 1 mul of [32P]-labeled hTR (0.1 pmol/mul), 1 mul of non-labeled hTR (0.4 pmol/mul) and 62.5 microg E. coli tRNA were mixed with 12.5 mul of the RRL-mix to give a final volume of 15.75 microl and incubated 1 h at 30degreesC. For pre-clearing, each reaction was mixed with 20 mul of 50% slurry of protein A beads (GE Healthcare) in IPIII buffer with 85 mul of IPIII buffer for 1 h at 4degreesC. The beads were removed by centrifugation at 16 100g for 1.5 min. Then the supernatant was incubated for 2 h at 4degreesC with 20 mul of the coated protein A beads with the respective antibodies. After immunoprecipitation, beads were recovered by spinning 1 min at 4000g and washed five times in 500 mul IPIII buffer. Samples were loaded on 4-20% gradient Tris-HCl PAGE duramide gels (Cambrex). After fixation following Cambrex instructions, gels were dried between two cellophane sheets (GE Healthcare). [35S]-labeled proteins and [32P]-labeled hTR were detected and quantified on a PhosphoImager. [32P]-labeled hTR could be distinguished from [35S]-labeled proteins by shielding the lower energy [35S]-derived beta-rays with a sheet of plastic.
###end p 23
###begin title 24
RESULTS
###end title 24
###begin title 25
Recombinant hEST1A associates with active telomerase
###end title 25
###begin p 26
###xml 279 287 279 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 423 431 423 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 552 560 552 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 842 844 842 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 857 859 857 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 1067 1075 1067 1075 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
To study the biochemical properties of hEST1A, we expressed recombinant hEST1A as an N-terminal glutathione (GST)-fusion protein from a baculoviral vector in Hi5 insect cells. Nuclear extracts were prepared and GST-hEST1A was purified on Sepharose-glutathione beads (GSH-beads) (Figure 1). Analysis of column eluates on Coomassie-brilliant blue stained polyacrylamide gels revealed one major band in the purified fraction (Figure 1A), which was recognized on western blots by GST-antibodies and hEST1A antibodies raised against the full-length hEST1A (Figure 1B). This indicates the presence of nearly homogeneously pure full-length GST-hEST1A in the eluted fractions. To test the ability of recombinant GST-hEST1A to associate with telomerase, the purified protein was incubated with telomerase, expressed and reconstituted in insect cells (17) or in RRL (20). Upon binding of GST-hEST1A via its tag to GSH-beads, the amount of associated telomerase activity was determined in TRAP telomerase activity assays, in which the products were quantified by real-time PCR (Figure 1C). Ten to thirty percent of telomerase activity associated with the beads in a GST-hEST1A-dependent manner indicating efficient association of recombinant EST1A with telomerase. GST alone did not bind substantial amounts of telomerase.
###end p 26
###begin title 27
Recombinant hEST1A binds telomerase RNA with high affinity but low specificity
###end title 27
###begin p 28
###xml 229 237 229 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 294 296 294 296 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 314 322 314 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 472 480 472 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 576 577 576 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 577 578 577 578 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 589 597 589 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 861 863 861 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kd</italic>
###xml 1147 1155 1147 1155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1253 1261 1253 1261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1381 1383 1377 1379 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1430 1438 1426 1434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1825 1833 1817 1825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 2090 2099 2070 2079 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2.</label>
###xml 2182 2183 2162 2163 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 2203 2205 2183 2185 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 2223 2231 2203 2211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 2701 2702 2681 2682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 2702 2703 2682 2683 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 2715 2716 2695 2696 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 3637 3638 3613 3614 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 4273 4280 4249 4256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 2099 4564 2079 4540 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="29">Recombinant GST&#8211;hEST1A interacts with hTR with high affinity but low specificity. (<bold>A</bold>) EMSA analysis of [<sup>32</sup>P] 5&#8242;-end labeled <italic>in vitro</italic> transcribed hTR (*hTR, 1 nM) with increasing amounts of purified GST&#8211;hEST1A (fraction E1). Lane 1: *hTR alone. Lane 2: *hTR incubated in EMSA buffer. Lanes 3&#8211;12: *hTR incubated with 0.83, 4.15, 8.3, 20.75, 33.2, 41.5, 53.95, 66.4, 83.0 and 166 nM of GST&#8211;hEST1A. GST&#8211;hEST1A&#8211;*hTR complexes are indicated. Right panel: Percentage of *hTR bound to GST&#8211;hEST1A plotted as a function of the concentration of GST&#8211;hEST1A. The experimental points fitted well with a curve with a <italic>K</italic><sub>d</sub> of 25 nM. (<bold>B</bold>) EMSA competition experiment to identify GST&#8211;hEST1A-binding specificity for different hTR domains. The secondary structure models are schematically depicted. Lane 1: *hTR alone. Lane 2: B: *hTR incubated with EMSA-buffer. Lanes 3&#8211;7: 50 nM GST&#8211;hEST1A (fraction E1) incubated with *hTR and increasing molar equivalent of unlabeled full-length hTR (5-, 10-, 50-, 100- and 500-fold excess). Lanes 8&#8211;13: 50 nM GST&#8211;hEST1A (fraction E1) incubated with *hTR and increasing molar equivalents of cold DCR45 (5-, 10-, 50-, 100-, 500- and 1000-fold excess). Lanes 14&#8211;19: 50 nM GST&#8211;hEST1A (fraction E1) incubated with *hTR and increasing molar equivalent of cold Pseudo (5-, 10-, 50-, 100-, 200- and 500-fold excess). Lanes 20&#8211;24: 50 nM GST&#8211;hEST1A (fraction E1) incubated with *hTR and increasing molar equivalent of cold &#916;Pseudo (5-, 10-, 50-, 100- and 500-fold excess). Right panel: Quantification of competition experiments. (<bold>C</bold>) EMSA competition experiment with additional RNA molecules. Lane 1: *hTR incubated with EMSA buffer. Lane 2: *hTR incubated with 50 nM GST&#8211;hEST1A (fraction E1). Lanes 3&#8211;8: 50 nM GST&#8211;hEST1A (fraction E1) incubated with *hTR and increasing mass equivalents of cold full-length hTR (6.25-, 12.5-, 25-, 62.5-, 100- and 250-fold mass excess over hTR). Lanes 9&#8211;13: 50 nM GST&#8211;hEST1A (fraction E1) incubated with *hTR and increasing quantity of cold gel purified ribosomal RNA (rRNA) (6.25-, 12.5-, 25-, 62.5- and 100-fold mass excess over hTR). Lanes 14&#8211;17: 50 nM GST&#8211;hEST1A (fraction E1) incubated with *hTR and increasing quantity of cold <italic>E. coli</italic> tRNA (100-, 250-, 450- and 1800-fold mass excess over hTR). Lanes 18&#8211;23: 50 nM GST&#8211;hEST1A (fraction E1) incubated with *hTR and increasing quantity of heparin (6.25-, 12.25-, 25-, 62.5-, 100- and 250-fold mass excess over hTR). Right panel: quantification of competition experiments.</p>
###xml 2099 4564 2079 4540 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="29">Recombinant GST&#8211;hEST1A interacts with hTR with high affinity but low specificity. (<bold>A</bold>) EMSA analysis of [<sup>32</sup>P] 5&#8242;-end labeled <italic>in vitro</italic> transcribed hTR (*hTR, 1 nM) with increasing amounts of purified GST&#8211;hEST1A (fraction E1). Lane 1: *hTR alone. Lane 2: *hTR incubated in EMSA buffer. Lanes 3&#8211;12: *hTR incubated with 0.83, 4.15, 8.3, 20.75, 33.2, 41.5, 53.95, 66.4, 83.0 and 166 nM of GST&#8211;hEST1A. GST&#8211;hEST1A&#8211;*hTR complexes are indicated. Right panel: Percentage of *hTR bound to GST&#8211;hEST1A plotted as a function of the concentration of GST&#8211;hEST1A. The experimental points fitted well with a curve with a <italic>K</italic><sub>d</sub> of 25 nM. (<bold>B</bold>) EMSA competition experiment to identify GST&#8211;hEST1A-binding specificity for different hTR domains. The secondary structure models are schematically depicted. Lane 1: *hTR alone. Lane 2: B: *hTR incubated with EMSA-buffer. Lanes 3&#8211;7: 50 nM GST&#8211;hEST1A (fraction E1) incubated with *hTR and increasing molar equivalent of unlabeled full-length hTR (5-, 10-, 50-, 100- and 500-fold excess). Lanes 8&#8211;13: 50 nM GST&#8211;hEST1A (fraction E1) incubated with *hTR and increasing molar equivalents of cold DCR45 (5-, 10-, 50-, 100-, 500- and 1000-fold excess). Lanes 14&#8211;19: 50 nM GST&#8211;hEST1A (fraction E1) incubated with *hTR and increasing molar equivalent of cold Pseudo (5-, 10-, 50-, 100-, 200- and 500-fold excess). Lanes 20&#8211;24: 50 nM GST&#8211;hEST1A (fraction E1) incubated with *hTR and increasing molar equivalent of cold &#916;Pseudo (5-, 10-, 50-, 100- and 500-fold excess). Right panel: Quantification of competition experiments. (<bold>C</bold>) EMSA competition experiment with additional RNA molecules. Lane 1: *hTR incubated with EMSA buffer. Lane 2: *hTR incubated with 50 nM GST&#8211;hEST1A (fraction E1). Lanes 3&#8211;8: 50 nM GST&#8211;hEST1A (fraction E1) incubated with *hTR and increasing mass equivalents of cold full-length hTR (6.25-, 12.5-, 25-, 62.5-, 100- and 250-fold mass excess over hTR). Lanes 9&#8211;13: 50 nM GST&#8211;hEST1A (fraction E1) incubated with *hTR and increasing quantity of cold gel purified ribosomal RNA (rRNA) (6.25-, 12.5-, 25-, 62.5- and 100-fold mass excess over hTR). Lanes 14&#8211;17: 50 nM GST&#8211;hEST1A (fraction E1) incubated with *hTR and increasing quantity of cold <italic>E. coli</italic> tRNA (100-, 250-, 450- and 1800-fold mass excess over hTR). Lanes 18&#8211;23: 50 nM GST&#8211;hEST1A (fraction E1) incubated with *hTR and increasing quantity of heparin (6.25-, 12.25-, 25-, 62.5-, 100- and 250-fold mass excess over hTR). Right panel: quantification of competition experiments.</p></caption>
###xml 4564 4564 4540 4540 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm724f2"/>
###xml 2090 4564 2070 4540 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F2" position="float"><label>Figure 2.</label><caption><p textid="29">Recombinant GST&#8211;hEST1A interacts with hTR with high affinity but low specificity. (<bold>A</bold>) EMSA analysis of [<sup>32</sup>P] 5&#8242;-end labeled <italic>in vitro</italic> transcribed hTR (*hTR, 1 nM) with increasing amounts of purified GST&#8211;hEST1A (fraction E1). Lane 1: *hTR alone. Lane 2: *hTR incubated in EMSA buffer. Lanes 3&#8211;12: *hTR incubated with 0.83, 4.15, 8.3, 20.75, 33.2, 41.5, 53.95, 66.4, 83.0 and 166 nM of GST&#8211;hEST1A. GST&#8211;hEST1A&#8211;*hTR complexes are indicated. Right panel: Percentage of *hTR bound to GST&#8211;hEST1A plotted as a function of the concentration of GST&#8211;hEST1A. The experimental points fitted well with a curve with a <italic>K</italic><sub>d</sub> of 25 nM. (<bold>B</bold>) EMSA competition experiment to identify GST&#8211;hEST1A-binding specificity for different hTR domains. The secondary structure models are schematically depicted. Lane 1: *hTR alone. Lane 2: B: *hTR incubated with EMSA-buffer. Lanes 3&#8211;7: 50 nM GST&#8211;hEST1A (fraction E1) incubated with *hTR and increasing molar equivalent of unlabeled full-length hTR (5-, 10-, 50-, 100- and 500-fold excess). Lanes 8&#8211;13: 50 nM GST&#8211;hEST1A (fraction E1) incubated with *hTR and increasing molar equivalents of cold DCR45 (5-, 10-, 50-, 100-, 500- and 1000-fold excess). Lanes 14&#8211;19: 50 nM GST&#8211;hEST1A (fraction E1) incubated with *hTR and increasing molar equivalent of cold Pseudo (5-, 10-, 50-, 100-, 200- and 500-fold excess). Lanes 20&#8211;24: 50 nM GST&#8211;hEST1A (fraction E1) incubated with *hTR and increasing molar equivalent of cold &#916;Pseudo (5-, 10-, 50-, 100- and 500-fold excess). Right panel: Quantification of competition experiments. (<bold>C</bold>) EMSA competition experiment with additional RNA molecules. Lane 1: *hTR incubated with EMSA buffer. Lane 2: *hTR incubated with 50 nM GST&#8211;hEST1A (fraction E1). Lanes 3&#8211;8: 50 nM GST&#8211;hEST1A (fraction E1) incubated with *hTR and increasing mass equivalents of cold full-length hTR (6.25-, 12.5-, 25-, 62.5-, 100- and 250-fold mass excess over hTR). Lanes 9&#8211;13: 50 nM GST&#8211;hEST1A (fraction E1) incubated with *hTR and increasing quantity of cold gel purified ribosomal RNA (rRNA) (6.25-, 12.5-, 25-, 62.5- and 100-fold mass excess over hTR). Lanes 14&#8211;17: 50 nM GST&#8211;hEST1A (fraction E1) incubated with *hTR and increasing quantity of cold <italic>E. coli</italic> tRNA (100-, 250-, 450- and 1800-fold mass excess over hTR). Lanes 18&#8211;23: 50 nM GST&#8211;hEST1A (fraction E1) incubated with *hTR and increasing quantity of heparin (6.25-, 12.25-, 25-, 62.5-, 100- and 250-fold mass excess over hTR). Right panel: quantification of competition experiments.</p></caption><graphic xlink:href="gkm724f2"/></fig>
###xml 4273 4280 <span type="species:ncbi:562">E. coli</span>
Association of hEST1A with telomerase may be mediated by protein-protein and/or protein-RNA interactions. In order to test the ability of hEST1A to bind the telomerase RNA moiety hTR, RNA band shift experiments were carried out (Figure 2). Increasing amounts of GST-hEST1A were incubated with [32P]-5'-end labeled in vitro transcribed hTR. Separation of the fractions on non-denaturing polyacrylamide gels indicated formation of slower migrating GST-hEST1A-hTR complexes (Figure 2A). The experimental data for overall hEST1A-hTR-binding fitted best a theoretical curve with a Kd of 25 nM (Figure 2A). The spread-out appearance of the GST-hEST1A-hTR complexes may be due to conformational flexibility, complex heterogeneity and concomitant binding of several hEST1A polypeptides per hTR molecule (see below). Thus this analysis gives an estimate for the overall Kd of hEST1A-hTR complexes without distinguishing individual subtypes. Other gel recipes, removal of the GST-tag from hEST1A or the use of hTR fragments did not reduce the heterogeneity. To test binding affinity for different domains of hTR, different fragments of hTR were transcribed in vitro and tested for their ability to inhibit the formation of the full-length GST-hEST1A-hTR complex (Figure 2B). The Delta-Pseudo fragment had a similar capacity as unlabeled full-length hTR, to compete for the formation of the [32P]-labeled full-length GST-hEST1A-hTR complex (Figure 2B). However, two other hTR fragments (Pseudo and DeltaCR45) also competed well with hTR for hEST1A-binding at slightly higher concentrations. Since the three tested hTR fragments contained distinct non-overlapping domains, this indicated several hEST1A-hTR interaction sites. To further address specificity of RNA binding, other non-related RNAs were tested in a competition experiment (Figure 2C). This experiment indicated that the affinity of hEST1A for rRNA is similar as for hTR, while tRNA competes only at approximately20-fold higher concentration, indicating very low affinity of hEST1A for this RNA. Heparin efficiently inhibited hTR binding. Figure 2.Recombinant GST-hEST1A interacts with hTR with high affinity but low specificity. (A) EMSA analysis of [32P] 5'-end labeled in vitro transcribed hTR (*hTR, 1 nM) with increasing amounts of purified GST-hEST1A (fraction E1). Lane 1: *hTR alone. Lane 2: *hTR incubated in EMSA buffer. Lanes 3-12: *hTR incubated with 0.83, 4.15, 8.3, 20.75, 33.2, 41.5, 53.95, 66.4, 83.0 and 166 nM of GST-hEST1A. GST-hEST1A-*hTR complexes are indicated. Right panel: Percentage of *hTR bound to GST-hEST1A plotted as a function of the concentration of GST-hEST1A. The experimental points fitted well with a curve with a Kd of 25 nM. (B) EMSA competition experiment to identify GST-hEST1A-binding specificity for different hTR domains. The secondary structure models are schematically depicted. Lane 1: *hTR alone. Lane 2: B: *hTR incubated with EMSA-buffer. Lanes 3-7: 50 nM GST-hEST1A (fraction E1) incubated with *hTR and increasing molar equivalent of unlabeled full-length hTR (5-, 10-, 50-, 100- and 500-fold excess). Lanes 8-13: 50 nM GST-hEST1A (fraction E1) incubated with *hTR and increasing molar equivalents of cold DCR45 (5-, 10-, 50-, 100-, 500- and 1000-fold excess). Lanes 14-19: 50 nM GST-hEST1A (fraction E1) incubated with *hTR and increasing molar equivalent of cold Pseudo (5-, 10-, 50-, 100-, 200- and 500-fold excess). Lanes 20-24: 50 nM GST-hEST1A (fraction E1) incubated with *hTR and increasing molar equivalent of cold DeltaPseudo (5-, 10-, 50-, 100- and 500-fold excess). Right panel: Quantification of competition experiments. (C) EMSA competition experiment with additional RNA molecules. Lane 1: *hTR incubated with EMSA buffer. Lane 2: *hTR incubated with 50 nM GST-hEST1A (fraction E1). Lanes 3-8: 50 nM GST-hEST1A (fraction E1) incubated with *hTR and increasing mass equivalents of cold full-length hTR (6.25-, 12.5-, 25-, 62.5-, 100- and 250-fold mass excess over hTR). Lanes 9-13: 50 nM GST-hEST1A (fraction E1) incubated with *hTR and increasing quantity of cold gel purified ribosomal RNA (rRNA) (6.25-, 12.5-, 25-, 62.5- and 100-fold mass excess over hTR). Lanes 14-17: 50 nM GST-hEST1A (fraction E1) incubated with *hTR and increasing quantity of cold E. coli tRNA (100-, 250-, 450- and 1800-fold mass excess over hTR). Lanes 18-23: 50 nM GST-hEST1A (fraction E1) incubated with *hTR and increasing quantity of heparin (6.25-, 12.25-, 25-, 62.5-, 100- and 250-fold mass excess over hTR). Right panel: quantification of competition experiments.
###end p 28
###begin p 29
###xml 83 84 83 84 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 104 106 104 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 124 132 124 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 602 603 602 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 603 604 603 604 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 616 617 616 617 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1538 1539 1534 1535 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 2174 2181 2170 2177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 2174 2181 <span type="species:ncbi:562">E. coli</span>
Recombinant GST-hEST1A interacts with hTR with high affinity but low specificity. (A) EMSA analysis of [32P] 5'-end labeled in vitro transcribed hTR (*hTR, 1 nM) with increasing amounts of purified GST-hEST1A (fraction E1). Lane 1: *hTR alone. Lane 2: *hTR incubated in EMSA buffer. Lanes 3-12: *hTR incubated with 0.83, 4.15, 8.3, 20.75, 33.2, 41.5, 53.95, 66.4, 83.0 and 166 nM of GST-hEST1A. GST-hEST1A-*hTR complexes are indicated. Right panel: Percentage of *hTR bound to GST-hEST1A plotted as a function of the concentration of GST-hEST1A. The experimental points fitted well with a curve with a Kd of 25 nM. (B) EMSA competition experiment to identify GST-hEST1A-binding specificity for different hTR domains. The secondary structure models are schematically depicted. Lane 1: *hTR alone. Lane 2: B: *hTR incubated with EMSA-buffer. Lanes 3-7: 50 nM GST-hEST1A (fraction E1) incubated with *hTR and increasing molar equivalent of unlabeled full-length hTR (5-, 10-, 50-, 100- and 500-fold excess). Lanes 8-13: 50 nM GST-hEST1A (fraction E1) incubated with *hTR and increasing molar equivalents of cold DCR45 (5-, 10-, 50-, 100-, 500- and 1000-fold excess). Lanes 14-19: 50 nM GST-hEST1A (fraction E1) incubated with *hTR and increasing molar equivalent of cold Pseudo (5-, 10-, 50-, 100-, 200- and 500-fold excess). Lanes 20-24: 50 nM GST-hEST1A (fraction E1) incubated with *hTR and increasing molar equivalent of cold DeltaPseudo (5-, 10-, 50-, 100- and 500-fold excess). Right panel: Quantification of competition experiments. (C) EMSA competition experiment with additional RNA molecules. Lane 1: *hTR incubated with EMSA buffer. Lane 2: *hTR incubated with 50 nM GST-hEST1A (fraction E1). Lanes 3-8: 50 nM GST-hEST1A (fraction E1) incubated with *hTR and increasing mass equivalents of cold full-length hTR (6.25-, 12.5-, 25-, 62.5-, 100- and 250-fold mass excess over hTR). Lanes 9-13: 50 nM GST-hEST1A (fraction E1) incubated with *hTR and increasing quantity of cold gel purified ribosomal RNA (rRNA) (6.25-, 12.5-, 25-, 62.5- and 100-fold mass excess over hTR). Lanes 14-17: 50 nM GST-hEST1A (fraction E1) incubated with *hTR and increasing quantity of cold E. coli tRNA (100-, 250-, 450- and 1800-fold mass excess over hTR). Lanes 18-23: 50 nM GST-hEST1A (fraction E1) incubated with *hTR and increasing quantity of heparin (6.25-, 12.25-, 25-, 62.5-, 100- and 250-fold mass excess over hTR). Right panel: quantification of competition experiments.
###end p 29
###begin p 30
###xml 82 83 82 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 367 375 367 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
Recombinant hEST1A has also been reported to bind telomeric DNA oligonucleotides (2). However, the RNA-binding domain of hEST1A appears distinct from the DNA-binding domain. First, telomeric and non-telomeric DNA oligonucleotides were not able to compete with formation of the GST-hEST1A-hTR complex even when present at a 1000-fold molar excess (Supplementary Data, Figure 1). Second, the DNA-binding domain of hEST1A has been mapped by Lea Harrington's laboratory (Toronto, personal communication) to a fragment encompassing amino acids 1-208 of hEST1A. This domain does not overlap with the hTR-binding domain of hEST1A (TRID), which has been mapped to amino acids 243-412 in the next section.
###end p 30
###begin title 31
Identification of the hTR-binding domain of hEST1A
###end title 31
###begin p 32
###xml 75 83 75 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 124 126 124 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 160 162 160 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 284 286 280 282 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 311 313 307 309 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 376 384 372 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 389 391 385 387 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 449 451 445 447 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 502 504 498 500 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 550 558 543 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 982 990 975 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 1062 1071 1055 1064 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3.</label>
###xml 1128 1129 1121 1122 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1311 1312 1304 1305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 1433 1435 1426 1428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 1522 1530 1515 1523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1655 1656 1648 1649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1661 1662 1654 1655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1665 1666 1658 1659 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1669 1671 1662 1664 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1689 1697 1682 1690 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1759 1761 1752 1754 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 2018 2020 2007 2009 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 2028 2030 2017 2019 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 2171 2173 2160 2162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 2366 2367 2355 2356 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1071 2593 1064 2582 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="33">Identification of the hEST1A hTR-binding domain (TRID). (<bold>A</bold>) Schematic representation of previously assigned hEST1A domains and hEST1A truncations. EST1, EST1 homology domain; TPR, tetratricopeptide repeats; PIN, PilT amino-terminal domain (<xref ref-type="bibr" rid="B1">1</xref>). The EST1 and TPR domains of the related SMG7/hEST1C form a 14-3-3 domain with a classic phosphoserine-binding pocket (<xref ref-type="bibr" rid="B31">31</xref>). For each polypeptide the association with TRAP activity is indicated [determined in <xref ref-type="fig" rid="F4">Figure 4</xref>; for hEST1A (1&#8211;855) association with TRAP activity is not shown (ns)]. TRID stands for hTR Interacting Domain identified in <italic>B</italic> and <italic>C</italic>. (<bold>B</bold>) [<sup>32</sup>P] 5&#8242;-end labeled <italic>in vitro</italic> transcribed hTR (*hTR) was incubated with in RRL translated [<sup>35</sup>S] methionine-labeled full-length hEST1A, full-length Flag-hEST1A (FL) and Flag-hEST1A fragments (amino acid fragments are indicated). After immunoprecipitation with &#945;-FLAG antibodies and five washes, samples were separated by 4&#8211;20% gradient SDS&#8211;PAGE. [<sup>35</sup>S] and [<sup>32</sup>P] signals were revealed by analysis on a PhosphoImager. Upon placing a plastic film between the gel and the PhosphoImager screen, only the [<sup>32</sup>P] signal was detected (lower part). Filled black arrows indicate the presence of the polypeptide in the immunoprecipitated fractions and empty arrows indicate the absence of the polypeptide. (<bold>C</bold>) Quantification of hTR associated with Flag-hEST1A fragments based on the gel in panel B and at least two additional experiments. The values were corrected by the immunoprecipitation efficiency of the individual polypeptides.</p>
###xml 1071 2593 1064 2582 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="33">Identification of the hEST1A hTR-binding domain (TRID). (<bold>A</bold>) Schematic representation of previously assigned hEST1A domains and hEST1A truncations. EST1, EST1 homology domain; TPR, tetratricopeptide repeats; PIN, PilT amino-terminal domain (<xref ref-type="bibr" rid="B1">1</xref>). The EST1 and TPR domains of the related SMG7/hEST1C form a 14-3-3 domain with a classic phosphoserine-binding pocket (<xref ref-type="bibr" rid="B31">31</xref>). For each polypeptide the association with TRAP activity is indicated [determined in <xref ref-type="fig" rid="F4">Figure 4</xref>; for hEST1A (1&#8211;855) association with TRAP activity is not shown (ns)]. TRID stands for hTR Interacting Domain identified in <italic>B</italic> and <italic>C</italic>. (<bold>B</bold>) [<sup>32</sup>P] 5&#8242;-end labeled <italic>in vitro</italic> transcribed hTR (*hTR) was incubated with in RRL translated [<sup>35</sup>S] methionine-labeled full-length hEST1A, full-length Flag-hEST1A (FL) and Flag-hEST1A fragments (amino acid fragments are indicated). After immunoprecipitation with &#945;-FLAG antibodies and five washes, samples were separated by 4&#8211;20% gradient SDS&#8211;PAGE. [<sup>35</sup>S] and [<sup>32</sup>P] signals were revealed by analysis on a PhosphoImager. Upon placing a plastic film between the gel and the PhosphoImager screen, only the [<sup>32</sup>P] signal was detected (lower part). Filled black arrows indicate the presence of the polypeptide in the immunoprecipitated fractions and empty arrows indicate the absence of the polypeptide. (<bold>C</bold>) Quantification of hTR associated with Flag-hEST1A fragments based on the gel in panel B and at least two additional experiments. The values were corrected by the immunoprecipitation efficiency of the individual polypeptides.</p></caption>
###xml 2593 2593 2582 2582 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm724f3"/>
###xml 1062 2593 1055 2582 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F3" position="float"><label>Figure 3.</label><caption><p textid="33">Identification of the hEST1A hTR-binding domain (TRID). (<bold>A</bold>) Schematic representation of previously assigned hEST1A domains and hEST1A truncations. EST1, EST1 homology domain; TPR, tetratricopeptide repeats; PIN, PilT amino-terminal domain (<xref ref-type="bibr" rid="B1">1</xref>). The EST1 and TPR domains of the related SMG7/hEST1C form a 14-3-3 domain with a classic phosphoserine-binding pocket (<xref ref-type="bibr" rid="B31">31</xref>). For each polypeptide the association with TRAP activity is indicated [determined in <xref ref-type="fig" rid="F4">Figure 4</xref>; for hEST1A (1&#8211;855) association with TRAP activity is not shown (ns)]. TRID stands for hTR Interacting Domain identified in <italic>B</italic> and <italic>C</italic>. (<bold>B</bold>) [<sup>32</sup>P] 5&#8242;-end labeled <italic>in vitro</italic> transcribed hTR (*hTR) was incubated with in RRL translated [<sup>35</sup>S] methionine-labeled full-length hEST1A, full-length Flag-hEST1A (FL) and Flag-hEST1A fragments (amino acid fragments are indicated). After immunoprecipitation with &#945;-FLAG antibodies and five washes, samples were separated by 4&#8211;20% gradient SDS&#8211;PAGE. [<sup>35</sup>S] and [<sup>32</sup>P] signals were revealed by analysis on a PhosphoImager. Upon placing a plastic film between the gel and the PhosphoImager screen, only the [<sup>32</sup>P] signal was detected (lower part). Filled black arrows indicate the presence of the polypeptide in the immunoprecipitated fractions and empty arrows indicate the absence of the polypeptide. (<bold>C</bold>) Quantification of hTR associated with Flag-hEST1A fragments based on the gel in panel B and at least two additional experiments. The values were corrected by the immunoprecipitation efficiency of the individual polypeptides.</p></caption><graphic xlink:href="gkm724f3"/></fig>
###xml 2593 2602 2582 2591 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4.</label>
###xml 2853 2854 2842 2843 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 3177 3178 3158 3159 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 2602 3320 2591 3297 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="34">Identification of a hEST1A fragment that binds active telomerase. The 293T cells were transiently transfected with expression vectors for full-length EST1A, full-length Flag-hEST1A (FL) and Flag-hEST1A fragments (amino acid fragments are indicated). (<bold>A</bold>) Upon immunoprecipitation with &#945;-FLAG antibodies and five washes, samples were loaded on 4&#8211;20% gradient SDS&#8211;polyacrylamide gels and FLAG-tagged EST1A fragments were revealed by western blotting with &#945;-FLAG antibodies. Input refers to extracts of the transiently transfected 293T cells before immunoprecipitation. (<bold>B</bold>) TRAP assay before and after immunoprecipitation with &#945;-FLAG antibodies. 3 and 1 refer to relative amounts of fraction used in the assay.</p>
###xml 2602 3320 2591 3297 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="34">Identification of a hEST1A fragment that binds active telomerase. The 293T cells were transiently transfected with expression vectors for full-length EST1A, full-length Flag-hEST1A (FL) and Flag-hEST1A fragments (amino acid fragments are indicated). (<bold>A</bold>) Upon immunoprecipitation with &#945;-FLAG antibodies and five washes, samples were loaded on 4&#8211;20% gradient SDS&#8211;polyacrylamide gels and FLAG-tagged EST1A fragments were revealed by western blotting with &#945;-FLAG antibodies. Input refers to extracts of the transiently transfected 293T cells before immunoprecipitation. (<bold>B</bold>) TRAP assay before and after immunoprecipitation with &#945;-FLAG antibodies. 3 and 1 refer to relative amounts of fraction used in the assay.</p></caption>
###xml 3320 3320 3297 3297 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm724f4"/>
###xml 2593 3320 2582 3297 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F4" position="float"><label>Figure 4.</label><caption><p textid="34">Identification of a hEST1A fragment that binds active telomerase. The 293T cells were transiently transfected with expression vectors for full-length EST1A, full-length Flag-hEST1A (FL) and Flag-hEST1A fragments (amino acid fragments are indicated). (<bold>A</bold>) Upon immunoprecipitation with &#945;-FLAG antibodies and five washes, samples were loaded on 4&#8211;20% gradient SDS&#8211;polyacrylamide gels and FLAG-tagged EST1A fragments were revealed by western blotting with &#945;-FLAG antibodies. Input refers to extracts of the transiently transfected 293T cells before immunoprecipitation. (<bold>B</bold>) TRAP assay before and after immunoprecipitation with &#945;-FLAG antibodies. 3 and 1 refer to relative amounts of fraction used in the assay.</p></caption><graphic xlink:href="gkm724f4"/></fig>
To map the hEST1A domain that mediates hTR binding, FLAG-hEST1A fragments (Figure 3A) were expressed in RRL in presence of [35S]-methionine and incubated with [32P]-labeled hTR. After immunoprecipitation of FLAG-hEST1A with alpha-FLAG antibodies, samples were separated by SDS-PAGE. [35S]-labeled proteins and [32P]-labeled hTR were detected upon analysis on a PhosphoImager (Figure 3B). [32P]-labeled hTR could be unequivocally distinguished from [35S]-labeled proteins by shielding the lower energy [35S]-derived beta-rays with a sheet of plastic (Figure 3B, lower part). In the absence of the FLAG-epitope (lane hEST1A_FL), neither hEST1A nor hTR was detected in the immunoprecipitate, demonstrating the specificity of the assay for FLAG-tagged hEST1A. A FLAG-hEST1A fragment encompassing amino acids 243-412 immunoprecipitated hTR even more efficiently than full-length FLAG-hEST1A, while FLAG-hEST1A fragments lacking this domain did not reveal efficient hTR-binding activity (Figure 3C). We therefore refer to this domain as hTR-interaction domain (TRID). Figure 3.Identification of the hEST1A hTR-binding domain (TRID). (A) Schematic representation of previously assigned hEST1A domains and hEST1A truncations. EST1, EST1 homology domain; TPR, tetratricopeptide repeats; PIN, PilT amino-terminal domain (1). The EST1 and TPR domains of the related SMG7/hEST1C form a 14-3-3 domain with a classic phosphoserine-binding pocket (31). For each polypeptide the association with TRAP activity is indicated [determined in Figure 4; for hEST1A (1-855) association with TRAP activity is not shown (ns)]. TRID stands for hTR Interacting Domain identified in B and C. (B) [32P] 5'-end labeled in vitro transcribed hTR (*hTR) was incubated with in RRL translated [35S] methionine-labeled full-length hEST1A, full-length Flag-hEST1A (FL) and Flag-hEST1A fragments (amino acid fragments are indicated). After immunoprecipitation with alpha-FLAG antibodies and five washes, samples were separated by 4-20% gradient SDS-PAGE. [35S] and [32P] signals were revealed by analysis on a PhosphoImager. Upon placing a plastic film between the gel and the PhosphoImager screen, only the [32P] signal was detected (lower part). Filled black arrows indicate the presence of the polypeptide in the immunoprecipitated fractions and empty arrows indicate the absence of the polypeptide. (C) Quantification of hTR associated with Flag-hEST1A fragments based on the gel in panel B and at least two additional experiments. The values were corrected by the immunoprecipitation efficiency of the individual polypeptides.Figure 4.Identification of a hEST1A fragment that binds active telomerase. The 293T cells were transiently transfected with expression vectors for full-length EST1A, full-length Flag-hEST1A (FL) and Flag-hEST1A fragments (amino acid fragments are indicated). (A) Upon immunoprecipitation with alpha-FLAG antibodies and five washes, samples were loaded on 4-20% gradient SDS-polyacrylamide gels and FLAG-tagged EST1A fragments were revealed by western blotting with alpha-FLAG antibodies. Input refers to extracts of the transiently transfected 293T cells before immunoprecipitation. (B) TRAP assay before and after immunoprecipitation with alpha-FLAG antibodies. 3 and 1 refer to relative amounts of fraction used in the assay.
###end p 32
###begin p 33
###xml 57 58 57 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 240 241 240 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 362 364 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 451 459 451 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 584 585 584 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 590 591 590 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 594 595 594 595 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 598 600 598 600 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 618 626 618 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 688 690 688 690 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 947 949 943 945 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 957 959 953 955 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1100 1102 1096 1098 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1295 1296 1291 1292 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
Identification of the hEST1A hTR-binding domain (TRID). (A) Schematic representation of previously assigned hEST1A domains and hEST1A truncations. EST1, EST1 homology domain; TPR, tetratricopeptide repeats; PIN, PilT amino-terminal domain (1). The EST1 and TPR domains of the related SMG7/hEST1C form a 14-3-3 domain with a classic phosphoserine-binding pocket (31). For each polypeptide the association with TRAP activity is indicated [determined in Figure 4; for hEST1A (1-855) association with TRAP activity is not shown (ns)]. TRID stands for hTR Interacting Domain identified in B and C. (B) [32P] 5'-end labeled in vitro transcribed hTR (*hTR) was incubated with in RRL translated [35S] methionine-labeled full-length hEST1A, full-length Flag-hEST1A (FL) and Flag-hEST1A fragments (amino acid fragments are indicated). After immunoprecipitation with alpha-FLAG antibodies and five washes, samples were separated by 4-20% gradient SDS-PAGE. [35S] and [32P] signals were revealed by analysis on a PhosphoImager. Upon placing a plastic film between the gel and the PhosphoImager screen, only the [32P] signal was detected (lower part). Filled black arrows indicate the presence of the polypeptide in the immunoprecipitated fractions and empty arrows indicate the absence of the polypeptide. (C) Quantification of hTR associated with Flag-hEST1A fragments based on the gel in panel B and at least two additional experiments. The values were corrected by the immunoprecipitation efficiency of the individual polypeptides.
###end p 33
###begin p 34
###xml 251 252 251 252 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 575 576 567 568 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
Identification of a hEST1A fragment that binds active telomerase. The 293T cells were transiently transfected with expression vectors for full-length EST1A, full-length Flag-hEST1A (FL) and Flag-hEST1A fragments (amino acid fragments are indicated). (A) Upon immunoprecipitation with alpha-FLAG antibodies and five washes, samples were loaded on 4-20% gradient SDS-polyacrylamide gels and FLAG-tagged EST1A fragments were revealed by western blotting with alpha-FLAG antibodies. Input refers to extracts of the transiently transfected 293T cells before immunoprecipitation. (B) TRAP assay before and after immunoprecipitation with alpha-FLAG antibodies. 3 and 1 refer to relative amounts of fraction used in the assay.
###end p 34
###begin title 35
TRID binds active telomerase
###end title 35
###begin p 36
###xml 347 355 339 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 418 426 410 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 538 546 530 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 869 877 861 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
To map the hEST1A domain, which mediates association with telomerase activity, FLAG-hEST1A fragments were transiently expressed in 293T cells and FLAG-hEST1A was immunoprecipitated with alpha-FLAG antibodies. Expression of FLAG-hEST1A fragments and their enrichment in the immunoprecipitate was tested in western blots with alpha-FLAG antibodies (Figure 4A). Presence of active telomerase was assessed in TRAP-assays (Figure 4B). As expected, immunoprecipitation of telomerase activity depended on presence of the FLAG epitope on hEST1A [Figure 4B, compare untagged hEST1A (lanes 7-8) with FLAG-hEST1A (lanes 9-10)]. Again, the FLAG-hEST1A fragment encompassing amino acids 243-412 was sufficient to immunoprecipitate telomerase activity while FLAG-hEST1A fragments lacking this domain immunoprecipitated considerably less (fragment 606-991) or no telomerase activity (Figure 4B). Thus, TRID is able to associate with active telomerase probably via its association with hTR.
###end p 36
###begin title 37
Identification of a hTERT fragment (EID) that binds hEST1A and hTR
###end title 37
###begin p 38
###xml 153 161 153 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 429 437 417 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 829 838 817 826 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5.</label>
###xml 900 901 888 889 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1013 1015 1001 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 1119 1120 1107 1108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1181 1182 1169 1170 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 838 1834 826 1810 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="39">Identification of an hTERT fragment (EID) that binds hEST1A. (<bold>A</bold>) Schematic representation of full-length hTERT and hTERT fragments. The different hTERT domains are indicated (<xref ref-type="bibr" rid="B32">32</xref>). For each polypeptide the molecular weight is given in kDa and the binding of hEST1A as determined in <italic>B</italic> is indicated (+, binding; &#8722;, no binding and ?, not known). (<bold>B</bold>) Transient co-expression in 293T cells of FLAG-hEST1A and full-length hTERT, full length Myc-hTERT (FL) or Myc-hTERT fragments (amino acid numbers are indicated). FLAG-hEST1A was immunoprecipitated using &#945;-FLAG antibodies. Upon immunoprecipitation and five washes, samples were loaded on 4&#8211;20% gradient SDS&#8211;polyacrylamide gels. The presence of Myc-hTERT fragments was determined by western blotting with &#945;-Myc antibodies and the immunoprecipitation efficiency was determined by western blotting with &#945;-FLAG antibodies. The presence of the polypeptides is indicated by black arrows whereas white arrows indicate absence of the polypeptides.</p>
###xml 838 1834 826 1810 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="39">Identification of an hTERT fragment (EID) that binds hEST1A. (<bold>A</bold>) Schematic representation of full-length hTERT and hTERT fragments. The different hTERT domains are indicated (<xref ref-type="bibr" rid="B32">32</xref>). For each polypeptide the molecular weight is given in kDa and the binding of hEST1A as determined in <italic>B</italic> is indicated (+, binding; &#8722;, no binding and ?, not known). (<bold>B</bold>) Transient co-expression in 293T cells of FLAG-hEST1A and full-length hTERT, full length Myc-hTERT (FL) or Myc-hTERT fragments (amino acid numbers are indicated). FLAG-hEST1A was immunoprecipitated using &#945;-FLAG antibodies. Upon immunoprecipitation and five washes, samples were loaded on 4&#8211;20% gradient SDS&#8211;polyacrylamide gels. The presence of Myc-hTERT fragments was determined by western blotting with &#945;-Myc antibodies and the immunoprecipitation efficiency was determined by western blotting with &#945;-FLAG antibodies. The presence of the polypeptides is indicated by black arrows whereas white arrows indicate absence of the polypeptides.</p></caption>
###xml 1834 1834 1810 1810 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm724f5"/>
###xml 829 1834 817 1810 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F5" position="float"><label>Figure 5.</label><caption><p textid="39">Identification of an hTERT fragment (EID) that binds hEST1A. (<bold>A</bold>) Schematic representation of full-length hTERT and hTERT fragments. The different hTERT domains are indicated (<xref ref-type="bibr" rid="B32">32</xref>). For each polypeptide the molecular weight is given in kDa and the binding of hEST1A as determined in <italic>B</italic> is indicated (+, binding; &#8722;, no binding and ?, not known). (<bold>B</bold>) Transient co-expression in 293T cells of FLAG-hEST1A and full-length hTERT, full length Myc-hTERT (FL) or Myc-hTERT fragments (amino acid numbers are indicated). FLAG-hEST1A was immunoprecipitated using &#945;-FLAG antibodies. Upon immunoprecipitation and five washes, samples were loaded on 4&#8211;20% gradient SDS&#8211;polyacrylamide gels. The presence of Myc-hTERT fragments was determined by western blotting with &#945;-Myc antibodies and the immunoprecipitation efficiency was determined by western blotting with &#945;-FLAG antibodies. The presence of the polypeptides is indicated by black arrows whereas white arrows indicate absence of the polypeptides.</p></caption><graphic xlink:href="gkm724f5"/></fig>
To identify a domain within hTERT that mediates interaction with hEST1A, we transiently co-expressed Myc-hTERT fragments with FLAG-hEST1A in 293T cells (Figure 5). Extracts were prepared and FLAG-hEST1A was immunoprecitated with alpha-FLAG antibodies. Presence of FLAG-hEST1A in the immunoprecipitate was checked in western blots with alpha-FLAG antibodies and co-immunoprecipitated hTERT was detected with alpha-Myc antibodies (Figure 5B). An hTERT fragment encompassing amino acids 147-311 efficiently associated with hEST1A and other hTERT fragments that contained this domain also immunoprecipitated FLAG-hEST1A. However, N-terminal fragments of hTERT (1-144 or 1-78) did not immunoprecipitate FLAG-hEST1A. We refer to the fragment encompassing amino acids 147-311, which binds hEST1A as EID (for hEST1A-interaction domain). Figure 5.Identification of an hTERT fragment (EID) that binds hEST1A. (A) Schematic representation of full-length hTERT and hTERT fragments. The different hTERT domains are indicated (32). For each polypeptide the molecular weight is given in kDa and the binding of hEST1A as determined in B is indicated (+, binding; -, no binding and ?, not known). (B) Transient co-expression in 293T cells of FLAG-hEST1A and full-length hTERT, full length Myc-hTERT (FL) or Myc-hTERT fragments (amino acid numbers are indicated). FLAG-hEST1A was immunoprecipitated using alpha-FLAG antibodies. Upon immunoprecipitation and five washes, samples were loaded on 4-20% gradient SDS-polyacrylamide gels. The presence of Myc-hTERT fragments was determined by western blotting with alpha-Myc antibodies and the immunoprecipitation efficiency was determined by western blotting with alpha-FLAG antibodies. The presence of the polypeptides is indicated by black arrows whereas white arrows indicate absence of the polypeptides.
###end p 38
###begin p 39
###xml 62 63 62 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 281 282 281 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 343 344 343 344 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
Identification of an hTERT fragment (EID) that binds hEST1A. (A) Schematic representation of full-length hTERT and hTERT fragments. The different hTERT domains are indicated (32). For each polypeptide the molecular weight is given in kDa and the binding of hEST1A as determined in B is indicated (+, binding; -, no binding and ?, not known). (B) Transient co-expression in 293T cells of FLAG-hEST1A and full-length hTERT, full length Myc-hTERT (FL) or Myc-hTERT fragments (amino acid numbers are indicated). FLAG-hEST1A was immunoprecipitated using alpha-FLAG antibodies. Upon immunoprecipitation and five washes, samples were loaded on 4-20% gradient SDS-polyacrylamide gels. The presence of Myc-hTERT fragments was determined by western blotting with alpha-Myc antibodies and the immunoprecipitation efficiency was determined by western blotting with alpha-FLAG antibodies. The presence of the polypeptides is indicated by black arrows whereas white arrows indicate absence of the polypeptides.
###end p 39
###begin p 40
###xml 164 166 164 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 207 209 207 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 220 228 220 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 246 254 246 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 360 362 356 358 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 387 389 383 385 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 457 465 453 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 711 719 707 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 721 730 717 726 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6.</label>
###xml 775 783 771 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 835 836 831 832 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 839 841 835 837 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 859 867 855 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 933 935 929 931 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 1229 1237 1221 1229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 1240 1241 1232 1233 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 730 1473 726 1465 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="41">RNA-binding activity of hTERT fragments (see <xref ref-type="fig" rid="F5">Figure 5</xref>A for schematic representation of the constructs). (<bold>A</bold>) [<sup>32</sup>P] 5&#8242;-end labeled <italic>in vitro</italic> transcribed hTR (*hTR) was incubated with in RRL in presence of [<sup>35</sup>S] methionine translated full-length FLAG-hTERT, full-length Myc-hTERT (FL) or Myc-hTERT fragments (amino acid numbers are indicated). Upon immunoprecipitation with &#945;-Myc antibodies and five washes, samples were loaded on 4&#8211;20% gradient SDS&#8211;polyacrylamide gels. The analysis was done as in <xref ref-type="fig" rid="F3">Figure 3</xref>. (<bold>B</bold>) Quantification of hTR associated (%) with the Myc-hTERT fragments based on the gel in panel A and at least two additional experiments. The values were corrected by the immunoprecipitation efficiency of the individual polypeptides.</p>
###xml 730 1473 726 1465 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="41">RNA-binding activity of hTERT fragments (see <xref ref-type="fig" rid="F5">Figure 5</xref>A for schematic representation of the constructs). (<bold>A</bold>) [<sup>32</sup>P] 5&#8242;-end labeled <italic>in vitro</italic> transcribed hTR (*hTR) was incubated with in RRL in presence of [<sup>35</sup>S] methionine translated full-length FLAG-hTERT, full-length Myc-hTERT (FL) or Myc-hTERT fragments (amino acid numbers are indicated). Upon immunoprecipitation with &#945;-Myc antibodies and five washes, samples were loaded on 4&#8211;20% gradient SDS&#8211;polyacrylamide gels. The analysis was done as in <xref ref-type="fig" rid="F3">Figure 3</xref>. (<bold>B</bold>) Quantification of hTR associated (%) with the Myc-hTERT fragments based on the gel in panel A and at least two additional experiments. The values were corrected by the immunoprecipitation efficiency of the individual polypeptides.</p></caption>
###xml 1473 1473 1465 1465 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm724f6"/>
###xml 721 1473 717 1465 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F6" position="float"><label>Figure 6.</label><caption><p textid="41">RNA-binding activity of hTERT fragments (see <xref ref-type="fig" rid="F5">Figure 5</xref>A for schematic representation of the constructs). (<bold>A</bold>) [<sup>32</sup>P] 5&#8242;-end labeled <italic>in vitro</italic> transcribed hTR (*hTR) was incubated with in RRL in presence of [<sup>35</sup>S] methionine translated full-length FLAG-hTERT, full-length Myc-hTERT (FL) or Myc-hTERT fragments (amino acid numbers are indicated). Upon immunoprecipitation with &#945;-Myc antibodies and five washes, samples were loaded on 4&#8211;20% gradient SDS&#8211;polyacrylamide gels. The analysis was done as in <xref ref-type="fig" rid="F3">Figure 3</xref>. (<bold>B</bold>) Quantification of hTR associated (%) with the Myc-hTERT fragments based on the gel in panel A and at least two additional experiments. The values were corrected by the immunoprecipitation efficiency of the individual polypeptides.</p></caption><graphic xlink:href="gkm724f6"/></fig>
To test if hEST1A binding by hTERT involves also hTR, we measured hTR-binding activity of different hTERT fragments. hTERT fragments were expressed in presence of [35S]-methionine in RRL and incubated with [32P]-labeled in vitro transcribed hTR (Figure 6). After immunoprecipitation of Myc-hTERT with alpha-Myc antibodies, samples were separated by SDS-PAGE. [35S]-labeled proteins and [32P]-labeled hTR were detected upon analysis on a PhosphoImager as in Figure 3. Weak hTR-binding activities were detected with Myc-hTERT-fragments containing amino acids 1-78, 1-144, 397-1132 and 707-1132. Most efficient hTR-binding activity was present in the EID-fragment (amino acids 147-311), which also bound hEST1A in Figure 5. Figure 6.RNA-binding activity of hTERT fragments (see Figure 5A for schematic representation of the constructs). (A) [32P] 5'-end labeled in vitro transcribed hTR (*hTR) was incubated with in RRL in presence of [35S] methionine translated full-length FLAG-hTERT, full-length Myc-hTERT (FL) or Myc-hTERT fragments (amino acid numbers are indicated). Upon immunoprecipitation with alpha-Myc antibodies and five washes, samples were loaded on 4-20% gradient SDS-polyacrylamide gels. The analysis was done as in Figure 3. (B) Quantification of hTR associated (%) with the Myc-hTERT fragments based on the gel in panel A and at least two additional experiments. The values were corrected by the immunoprecipitation efficiency of the individual polypeptides.
###end p 40
###begin p 41
###xml 45 53 45 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 105 106 105 106 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 109 111 109 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 129 137 129 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 203 205 203 205 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 499 507 495 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 510 511 506 507 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
RNA-binding activity of hTERT fragments (see Figure 5A for schematic representation of the constructs). (A) [32P] 5'-end labeled in vitro transcribed hTR (*hTR) was incubated with in RRL in presence of [35S] methionine translated full-length FLAG-hTERT, full-length Myc-hTERT (FL) or Myc-hTERT fragments (amino acid numbers are indicated). Upon immunoprecipitation with alpha-Myc antibodies and five washes, samples were loaded on 4-20% gradient SDS-polyacrylamide gels. The analysis was done as in Figure 3. (B) Quantification of hTR associated (%) with the Myc-hTERT fragments based on the gel in panel A and at least two additional experiments. The values were corrected by the immunoprecipitation efficiency of the individual polypeptides.
###end p 41
###begin title 42
###xml 68 73 <span type="species:ncbi:9606">human</span>
Protein-RNA and protein-protein interactions mediate association of human EST1A with hTERT
###end title 42
###begin p 43
###xml 410 418 410 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 603 611 603 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 931 939 931 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 1236 1244 1236 1244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 1686 1694 1686 1694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 1761 1770 1761 1770 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 7.</label>
###xml 1928 1936 1928 1936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 1959 1967 1959 1967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 2122 2123 2122 2123 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 2583 2584 2557 2558 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 3269 3270 3217 3218 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 3595 3596 3527 3528 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1770 3856 1770 3780 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="44">Protein&#8211;RNA and protein&#8211;protein interactions mediate association of human EST1A with hTERT. The indicated polypeptides were transiently co-expressed in 293T (<xref ref-type="fig" rid="F7">Figure 7</xref>A and B) or WI38-VA13 (<xref ref-type="fig" rid="F7">Figure 7</xref>D) cells and immunoprecipitated (IP) with the indicated antibodies. Polypeptides were revealed by western blotting with antibodies indicated on the left. (<bold>A</bold>) 293T cell extracts (600 &#181;l) were either treated (+) or not treated (&#8722;) with 3 &#181;g RNase A for 10 min at 25&#176;C before starting the immunoprecipitation with &#945;-FLAG antibody. After five washes, samples were loaded on 4&#8211;20% gradient SDS&#8211;polyacrylamide gels. The presence of Myc-EID was determined by western blotting with &#945;-Myc antibodies and the immunoprecipitation efficiency was determined by western blotting with &#945;-FLAG antibodies. (<bold>B</bold>) Transient co-transfection in 293T cells of Flag-hEST1A and full-length FLAG-hTERT, full-length Myc-hTERT (FL) and Myc-EID. Immunoprecipitations were carried out with &#945;-Myc antibodies. After five washes, the beads were either treated (+) or not treated (&#8722;) or with 0.5 &#181;g RNase A/12 &#181;l for 10 min at 25&#176;C. The eluate (E) was also analyzed to check for the release of Flag-hEST1A. The beads were washed one time before being loaded on 4&#8211;20% gradient SDS&#8211;polyacrylamide gels. The presence of Flag-hEST1A was determined by western blotting with &#945;-FLAG antibodies and the immunoprecipitation efficiency was determined by western blotting with &#945;-Myc antibodies. (<bold>C</bold>) Dot blot analysis of total RNA extracted from 293T cell extracts before and after RNase A treatment, revealed with a randomly labeled full-length hTR probe. Extracts (Input) were treated with 0.005 &#181;g RNase A/&#181;l of extract and beads (IP) were treated with 0.04 &#181;g of RNase A/&#181;l of bead suspension as in B. (<bold>D</bold>) Transient co-transfection in WI38-VA13 cells of Flag-hEST1A and full-length FLAG-hTERT, full-length Myc-hTERT (FL) and Myc-EID. Immunoprecipitations were carried out with &#945;-Myc antibodies (left panel) or &#945;-Flag antibodies (right panel) as in A and B.</p>
###xml 1770 3856 1770 3780 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="44">Protein&#8211;RNA and protein&#8211;protein interactions mediate association of human EST1A with hTERT. The indicated polypeptides were transiently co-expressed in 293T (<xref ref-type="fig" rid="F7">Figure 7</xref>A and B) or WI38-VA13 (<xref ref-type="fig" rid="F7">Figure 7</xref>D) cells and immunoprecipitated (IP) with the indicated antibodies. Polypeptides were revealed by western blotting with antibodies indicated on the left. (<bold>A</bold>) 293T cell extracts (600 &#181;l) were either treated (+) or not treated (&#8722;) with 3 &#181;g RNase A for 10 min at 25&#176;C before starting the immunoprecipitation with &#945;-FLAG antibody. After five washes, samples were loaded on 4&#8211;20% gradient SDS&#8211;polyacrylamide gels. The presence of Myc-EID was determined by western blotting with &#945;-Myc antibodies and the immunoprecipitation efficiency was determined by western blotting with &#945;-FLAG antibodies. (<bold>B</bold>) Transient co-transfection in 293T cells of Flag-hEST1A and full-length FLAG-hTERT, full-length Myc-hTERT (FL) and Myc-EID. Immunoprecipitations were carried out with &#945;-Myc antibodies. After five washes, the beads were either treated (+) or not treated (&#8722;) or with 0.5 &#181;g RNase A/12 &#181;l for 10 min at 25&#176;C. The eluate (E) was also analyzed to check for the release of Flag-hEST1A. The beads were washed one time before being loaded on 4&#8211;20% gradient SDS&#8211;polyacrylamide gels. The presence of Flag-hEST1A was determined by western blotting with &#945;-FLAG antibodies and the immunoprecipitation efficiency was determined by western blotting with &#945;-Myc antibodies. (<bold>C</bold>) Dot blot analysis of total RNA extracted from 293T cell extracts before and after RNase A treatment, revealed with a randomly labeled full-length hTR probe. Extracts (Input) were treated with 0.005 &#181;g RNase A/&#181;l of extract and beads (IP) were treated with 0.04 &#181;g of RNase A/&#181;l of bead suspension as in B. (<bold>D</bold>) Transient co-transfection in WI38-VA13 cells of Flag-hEST1A and full-length FLAG-hTERT, full-length Myc-hTERT (FL) and Myc-EID. Immunoprecipitations were carried out with &#945;-Myc antibodies (left panel) or &#945;-Flag antibodies (right panel) as in A and B.</p></caption>
###xml 3856 3856 3780 3780 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm724f7"/>
###xml 1761 3856 1761 3780 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F7" position="float"><label>Figure 7.</label><caption><p textid="44">Protein&#8211;RNA and protein&#8211;protein interactions mediate association of human EST1A with hTERT. The indicated polypeptides were transiently co-expressed in 293T (<xref ref-type="fig" rid="F7">Figure 7</xref>A and B) or WI38-VA13 (<xref ref-type="fig" rid="F7">Figure 7</xref>D) cells and immunoprecipitated (IP) with the indicated antibodies. Polypeptides were revealed by western blotting with antibodies indicated on the left. (<bold>A</bold>) 293T cell extracts (600 &#181;l) were either treated (+) or not treated (&#8722;) with 3 &#181;g RNase A for 10 min at 25&#176;C before starting the immunoprecipitation with &#945;-FLAG antibody. After five washes, samples were loaded on 4&#8211;20% gradient SDS&#8211;polyacrylamide gels. The presence of Myc-EID was determined by western blotting with &#945;-Myc antibodies and the immunoprecipitation efficiency was determined by western blotting with &#945;-FLAG antibodies. (<bold>B</bold>) Transient co-transfection in 293T cells of Flag-hEST1A and full-length FLAG-hTERT, full-length Myc-hTERT (FL) and Myc-EID. Immunoprecipitations were carried out with &#945;-Myc antibodies. After five washes, the beads were either treated (+) or not treated (&#8722;) or with 0.5 &#181;g RNase A/12 &#181;l for 10 min at 25&#176;C. The eluate (E) was also analyzed to check for the release of Flag-hEST1A. The beads were washed one time before being loaded on 4&#8211;20% gradient SDS&#8211;polyacrylamide gels. The presence of Flag-hEST1A was determined by western blotting with &#945;-FLAG antibodies and the immunoprecipitation efficiency was determined by western blotting with &#945;-Myc antibodies. (<bold>C</bold>) Dot blot analysis of total RNA extracted from 293T cell extracts before and after RNase A treatment, revealed with a randomly labeled full-length hTR probe. Extracts (Input) were treated with 0.005 &#181;g RNase A/&#181;l of extract and beads (IP) were treated with 0.04 &#181;g of RNase A/&#181;l of bead suspension as in B. (<bold>D</bold>) Transient co-transfection in WI38-VA13 cells of Flag-hEST1A and full-length FLAG-hTERT, full-length Myc-hTERT (FL) and Myc-EID. Immunoprecipitations were carried out with &#945;-Myc antibodies (left panel) or &#945;-Flag antibodies (right panel) as in A and B.</p></caption><graphic xlink:href="gkm724f7"/></fig>
###xml 1838 1843 <span type="species:ncbi:9606">human</span>
The above experiments delineated hEST1A and hTERT domains that at the same time mediated the interaction between hEST1A and hTERT as well as with hTR. To test the hypothesis that the interaction between hEST1A and hTERT was mediated by hTR, we transiently co-expressed hEST1A and hTERT fragments in 293T cells and tested their interaction by co-immunoprecipitation upon treatment of the extracts with RNase A (Figure 7). The extent of hTR destruction by RNase A treatment was determined by assessing presence of hTR upon Northern hybridization of dotblots with a randomly labeled full-length hTR probe (Figure 7C). Approximately 99% of the hTR signal disappeared in extracts and more than 95% of the signal disappeared in the immunoprecipitates upon RNase A treatment. Immunoprecipitated full-length FLAG-hEST1A co-immunoprecipitated Myc-EID (hTERT-fragment 147-311) and this interaction was not alleviated upon RNase A treatment (Figure 7A, compare lanes 5 and 6 on the right panel). Thus, while EID is able to bind hTR it establishes also protein-protein contacts with hEST1A. In contrast, when a TRID-containing FLAG-hEST1A fragment [hEST1A-fragment (243-533)] was immunoprecipitated, the interaction with EID was RNase A sensitive (Figure 7A, compare lanes 7 and 8 on the right panel). Thus, EID cannot establish stable protein-protein contacts with TRID as observed with full-length hEST1A. Consistent with these results, when either full-length Myc-hTERT or Myc-EID were co-expressed with full-length FLAG-hEST1A and immunoprecipitated, FLAG-hEST1A remained associated with Myc-hTERT as well as with Myc-EID even upon RNase A treatment of the beads after the immunoprecipitation (Figure 7B, compare in the right panel lanes 5 with 7 and lanes 9 with 11). Figure 7.Protein-RNA and protein-protein interactions mediate association of human EST1A with hTERT. The indicated polypeptides were transiently co-expressed in 293T (Figure 7A and B) or WI38-VA13 (Figure 7D) cells and immunoprecipitated (IP) with the indicated antibodies. Polypeptides were revealed by western blotting with antibodies indicated on the left. (A) 293T cell extracts (600 microl) were either treated (+) or not treated (-) with 3 microg RNase A for 10 min at 25degreesC before starting the immunoprecipitation with alpha-FLAG antibody. After five washes, samples were loaded on 4-20% gradient SDS-polyacrylamide gels. The presence of Myc-EID was determined by western blotting with alpha-Myc antibodies and the immunoprecipitation efficiency was determined by western blotting with alpha-FLAG antibodies. (B) Transient co-transfection in 293T cells of Flag-hEST1A and full-length FLAG-hTERT, full-length Myc-hTERT (FL) and Myc-EID. Immunoprecipitations were carried out with alpha-Myc antibodies. After five washes, the beads were either treated (+) or not treated (-) or with 0.5 microg RNase A/12 microl for 10 min at 25degreesC. The eluate (E) was also analyzed to check for the release of Flag-hEST1A. The beads were washed one time before being loaded on 4-20% gradient SDS-polyacrylamide gels. The presence of Flag-hEST1A was determined by western blotting with alpha-FLAG antibodies and the immunoprecipitation efficiency was determined by western blotting with alpha-Myc antibodies. (C) Dot blot analysis of total RNA extracted from 293T cell extracts before and after RNase A treatment, revealed with a randomly labeled full-length hTR probe. Extracts (Input) were treated with 0.005 microg RNase A/microl of extract and beads (IP) were treated with 0.04 microg of RNase A/microl of bead suspension as in B. (D) Transient co-transfection in WI38-VA13 cells of Flag-hEST1A and full-length FLAG-hTERT, full-length Myc-hTERT (FL) and Myc-EID. Immunoprecipitations were carried out with alpha-Myc antibodies (left panel) or alpha-Flag antibodies (right panel) as in A and B.
###end p 43
###begin p 44
###xml 158 166 158 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 189 197 189 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 352 353 352 353 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 813 814 787 788 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1499 1500 1447 1448 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1825 1826 1757 1758 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 68 73 <span type="species:ncbi:9606">human</span>
Protein-RNA and protein-protein interactions mediate association of human EST1A with hTERT. The indicated polypeptides were transiently co-expressed in 293T (Figure 7A and B) or WI38-VA13 (Figure 7D) cells and immunoprecipitated (IP) with the indicated antibodies. Polypeptides were revealed by western blotting with antibodies indicated on the left. (A) 293T cell extracts (600 microl) were either treated (+) or not treated (-) with 3 microg RNase A for 10 min at 25degreesC before starting the immunoprecipitation with alpha-FLAG antibody. After five washes, samples were loaded on 4-20% gradient SDS-polyacrylamide gels. The presence of Myc-EID was determined by western blotting with alpha-Myc antibodies and the immunoprecipitation efficiency was determined by western blotting with alpha-FLAG antibodies. (B) Transient co-transfection in 293T cells of Flag-hEST1A and full-length FLAG-hTERT, full-length Myc-hTERT (FL) and Myc-EID. Immunoprecipitations were carried out with alpha-Myc antibodies. After five washes, the beads were either treated (+) or not treated (-) or with 0.5 microg RNase A/12 microl for 10 min at 25degreesC. The eluate (E) was also analyzed to check for the release of Flag-hEST1A. The beads were washed one time before being loaded on 4-20% gradient SDS-polyacrylamide gels. The presence of Flag-hEST1A was determined by western blotting with alpha-FLAG antibodies and the immunoprecipitation efficiency was determined by western blotting with alpha-Myc antibodies. (C) Dot blot analysis of total RNA extracted from 293T cell extracts before and after RNase A treatment, revealed with a randomly labeled full-length hTR probe. Extracts (Input) were treated with 0.005 microg RNase A/microl of extract and beads (IP) were treated with 0.04 microg of RNase A/microl of bead suspension as in B. (D) Transient co-transfection in WI38-VA13 cells of Flag-hEST1A and full-length FLAG-hTERT, full-length Myc-hTERT (FL) and Myc-EID. Immunoprecipitations were carried out with alpha-Myc antibodies (left panel) or alpha-Flag antibodies (right panel) as in A and B.
###end p 44
###begin p 45
###xml 238 246 238 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 302 310 302 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 184 189 <span type="species:ncbi:9606">human</span>
To further corroborate hTR-independent interactions between hTERT and hEST1A, we assessed the interaction between both polypeptides upon transient expression in WI38-VA13, an immortal human fibroblast cell line that does not express hTR (Figure 7D). Again, Myc-hTERT co-immunoprecipitated Flag-hEST1A (Figure 7D, left panel) and Flag-hEST1A co-immunoprecipitated Myc-hTERT and Myc-EID. This therefore confirms that full-length Myc-hTERT and Myc-EID interact with hEST1A also in the absence of hTR via protein-protein contacts.
###end p 45
###begin title 46
DISCUSSION
###end title 46
###begin p 47
###xml 64 77 64 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. cerevisiae</italic>
###xml 780 781 780 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 947 955 947 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1077 1079 1077 1079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 1091 1098 1091 1098 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1213 1215 1213 1215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 1325 1332 1325 1332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1553 1555 1553 1555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1556 1558 1556 1558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 64 77 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 961 966 <span type="species:ncbi:4932">yeast</span>
###xml 1025 1030 <span type="species:ncbi:4932">yeast</span>
###xml 1158 1163 <span type="species:ncbi:9606">human</span>
###xml 1260 1265 <span type="species:ncbi:4932">yeast</span>
Human EST1A was discovered through its sequence similarity with S. cerevisiae Est1p but its precise function at telomeres has remained unclear. We show here that hEST1A associates with telomerase through dual interactions with the telomerase RNA moiety and the TERT. The TRID is contained within a 168 amino acid fragment in the N-terminal part of hEST1A, a region that does not contain any recognizable structural motifs or sequence homologies with other proteins in the database. TRID binds to hTR with high overall affinity (25 nM) but low specificity. Distinct non-overlapping fragments of hTR as well as rRNA competed for binding of full-length hTR with similar efficiency while tRNA was a poor ligand for hEST1A. TRID is also distinct from the DNA-binding domain of hEST1A (2), which resides more N-terminal [amino acids 1-208, Lea Harrington's laboratory (Toronto, personal communication)]. Low specificity of RNA binding was also observed in vitro with yeast Est1p, which displayed a similar affinity (50 nM) for the yeast telomerase RNA TLC1 and other RNA substrates (21). However, in vivo a bulged stem of TLC1, which has no obvious counterpart in human telomerase RNA, mediates association with Est1p (22). Thus, it is conceivable that similarly to yeast Est1p, hEST1A also interacts with a specific hTR structure in vivo in the context of the assembled hTR-hTERT complex. This would be analogous to some ribosomal proteins, which achieve RNA sequence-specific binding only in the context of a partially assembled ribonucleoprotein particle (23,24).
###end p 47
###begin p 48
###xml 443 444 443 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 705 707 705 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
Consistent with this notion, we also identify protein-mediated interactions between hEST1A and TERT. TRID interacts with EID in a strictly RNA-dependent manner whereas full-length hEST1A remains associated with hTERT or with EID even upon digestion of hTR with RNases, or when expressed in a cell line that lacks hTR. Consistent with our results in cell culture, telomerase RNA-independent association of hEST1A and hTERT was observed in RRL (2). It remains to be determined which domains outside of TRID establish protein-mediated interactions with TERT. Interestingly, the EST1/TPR domain of the hEST1A/SMG6-related SMG7/hEST1C polypeptide has a 14-3-3 fold with a classic phosphoserine-binding pocket (25). However, other regions of the protein could also be involved.
###end p 48
###begin p 49
###xml 359 361 359 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 471 473 471 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 647 655 647 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 827 829 827 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 1058 1069 1054 1065 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tetrahymena</italic>
###xml 1305 1307 1301 1303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 1501 1508 1497 1504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1510 1512 1506 1508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 1114 1119 <span type="species:ncbi:9606">human</span>
We also identified a TERT domain that associates with hEST1A. The EID is comprised between amino acids 147-311. EID contains hTR-binding activity and at the same time it establishes RNase-resistant contacts with hEST1A. Previous studies with hTERT have identified two regions responsible for interactions with TR, termed RNA interaction domain (RID) 1 and 2 (26). The C-terminal part of RID1 (amino acids 1-250), which associates with the hTR template-pseudoknot domain (27) overlaps with the N-terminal part of EID (amino acids 147-311). A hTERT fragment containing the entire RID1 and EID regions did not pull-down more hTR than EID on its own (Figure 6) suggesting that EID and RID1 contain one and the same RNA-binding domain. However, deletion of residues 1-24 in RID1 abolished binding of the template-pseudoknot domain (27), suggesting that either the RNA-binding activity in EID is distinct from RID1 or that the 1-25Delta RID1-mutant displayed a folding problem that abolished RNA-binding activity. Interestingly, the recently solved structure of a Tetrahymena TERT region named TEN, which corresponds to human RID1, shows a positively charged flexible C-terminal tail. This tail, which is present at the N-terminus of EID has been proposed to be involved in telomerase protein-RNA interactions (28). No functions have been assigned before to the C-terminal part of EID. Scanning mutagenesis with short linkers did not identify hTERT-mutants in this region that abolished telomerase function in vivo (29), but protein-protein interactions may involve larger surfaces that were not fully inactivated with this approach. Furthermore, hEST1A-hTR interactions may partially compensate for the loss of direct hTERT-hEST1A contacts.
###end p 49
###begin p 50
###xml 221 222 221 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 311 313 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 338 351 338 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. cerevisiae</italic>
###xml 489 490 489 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 566 574 566 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 641 643 641 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 644 646 644 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 781 789 781 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 935 948 935 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. cerevisiae</italic>
###xml 999 1007 999 1007 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 18 23 <span type="species:ncbi:9606">human</span>
###xml 338 351 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 512 517 <span type="species:ncbi:9606">human</span>
###xml 935 948 <span type="species:ncbi:4932">S. cerevisiae</span>
The regulation of human telomerase at telomeres and the putative role of hEST1A in this process are poorly understood at the molecular level. The functional analysis of hEST1A has been hampered by its involvement in NMD (3) and essential roles of hEST1A for S-phase progression presumably in conjunction UPF1 ((12) and unpublished data). S. cerevisiae Est1p is thought to mediate telomerase recruitment through its direct interaction with Cdc13p, which binds to the telomeric 3' overhang (8). POT1, the putative human ortholog of Cdc13p inhibits telomerase activity in vitro when bound to the 3'end of a telomeric oligonucleotide substrate (19,30). Trials to detect a physical interaction between POT1 and hEST1A have been unsuccessful so far and addition of recombinant hEST1A to in vitro assays could also not alleviate the inhibitory effects of POT1 on telomerase activity (our unpublished data). However, telomerase recruitment by S. cerevisiae Cdc13p and Est1p has also not yet been reproduced in vitro. The here reported identification and characterization of functional domains of hEST1A that mediate interaction with telomerase may allow to specifically disrupt these interactions to understand the possible roles of hEST1A in telomere length control and telomere capping.
###end p 50
###begin title 51
SUPPLEMENTARY DATA
###end title 51
###begin p 52
Supplementary Data are available at NAR Online.
###end p 52
###begin title 53
Supplementary Material
###end title 53
###begin title 54
[Supplementary Data]
###end title 54
###begin title 55
ACKNOWLEDGEMENTS
###end title 55
###begin p 56
###xml 322 327 <span type="species:ncbi:9606">Human</span>
We thank Isabel Kurth for affinity-purified telomerase from insect cells and for technical advice, Claus Azzalin for comments on the manuscript and Lea Harrington for communicating unpublished results. Work in the laboratory was supported by grants from the Swiss National Science Foundation, the Swiss Cancer League, the Human Frontier Science Program and the EU 6th Framework Programme. Funding to pay the Open Access publication charges for this article was provided by HFSP.
###end p 56
###begin p 57
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement</italic>
Conflict of interest statement. None declared.
###end p 57
###begin title 58
REFERENCES
###end title 58
###begin article-title 59
###xml 2 7 <span type="species:ncbi:9606">human</span>
###xml 19 24 <span type="species:ncbi:4932">yeast</span>
A human homolog of yeast Est1 associates with telomerase and uncaps chromosome ends when overexpressed
###end article-title 59
###begin article-title 60
###xml 59 65 <span type="species:ncbi:9606">humans</span>
Functional conservation of the telomerase protein Est1p in humans
###end article-title 60
###begin article-title 61
###xml 66 88 66 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Caenorhabditis elegans</italic>
###xml 20 25 <span type="species:ncbi:9606">human</span>
###xml 66 88 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
Characterization of human Smg5/7a: a protein with similarities to Caenorhabditis elegans SMG5 and SMG7 that functions in the dephosphorylation of Upf1
###end article-title 61
###begin article-title 62
###xml 14 19 <span type="species:ncbi:9606">human</span>
TRF2 protects human telomeres from end-to-end fusions
###end article-title 62
###begin article-title 63
DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion
###end article-title 63
###begin article-title 64
###xml 69 74 <span type="species:ncbi:4932">yeast</span>
A mutant with a defect in telomere elongation leads to senescence in yeast
###end article-title 64
###begin article-title 65
###xml 24 37 <span type="species:ncbi:4896">fission yeast</span>
Telomere maintenance in fission yeast requires an Est1 ortholog
###end article-title 65
###begin article-title 66
Cdc13 delivers separate complexes to the telomere for end protection and replication
###end article-title 66
###begin article-title 67
###xml 32 42 32 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 71 76 <span type="species:ncbi:4932">yeast</span>
Nonsense-mediated mRNA decay in Drosophila: at the intersection of the yeast and mammalian pathways
###end article-title 67
###begin article-title 68
Phosphorylation of hUPF1 induces formation of mRNA surveillance complexes containing hSMG-5 and hSMG-7
###end article-title 68
###begin article-title 69
###xml 54 59 <span type="species:ncbi:9606">human</span>
Characterization of the biochemical properties of the human Upf1 gene product that is involved in nonsense-mediated mRNA decay
###end article-title 69
###begin article-title 70
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human RNA surveillance factor UPF1 is required for S phase progression and genome stability
###end article-title 70
###begin article-title 71
The mRNA surveillance protein hSMG-1 functions in genotoxic stress response pathways in mammalian cells
###end article-title 71
###begin article-title 72
hUPF2 silencing identifies physiologic substrates of mammalian nonsense-mediated mRNA decay
###end article-title 72
###begin article-title 73
Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells
###end article-title 73
###begin article-title 74
Site-directed mutagenesis by overlap extension using the polymerase chain reaction
###end article-title 74
###begin article-title 75
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human telomerase contains two cooperating telomerase RNA molecules
###end article-title 75
###begin article-title 76
Telomere length homeostasis requires that telomerase levels are limiting
###end article-title 76
###begin article-title 77
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human protection of telomeres 1 (POT1) is a negative regulator of telomerase activity in vitro
###end article-title 77
###begin article-title 78
###xml 18 23 <span type="species:ncbi:9606">human</span>
Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT
###end article-title 78
###begin article-title 79
Est1 has the properties of a single-stranded telomere end-binding protein
###end article-title 79
###begin article-title 80
###xml 57 62 <span type="species:ncbi:4932">yeast</span>
A bulged stem tethers Est1p to telomerase RNA in budding yeast
###end article-title 80
###begin article-title 81
The roles of ribosomal proteins in the structure assembly, and evolution of the large ribosomal subunit
###end article-title 81
###begin article-title 82
###xml 53 73 53 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Thermus thermophilus</italic>
###xml 53 73 <span type="species:ncbi:274">Thermus thermophilus</span>
Crystal structure of the 30 S ribosomal subunit from Thermus thermophilus: structure of the proteins and their interactions with 16 S RNA
###end article-title 82
###begin article-title 83
SMG7 is a 14-3-3-like adaptor in the nonsense-mediated mRNA decay pathway
###end article-title 83
###begin article-title 84
###xml 30 35 <span type="species:ncbi:9606">human</span>
Functional multimerization of human telomerase requires an RNA interaction domain in the N terminus of the catalytic subunit
###end article-title 84
###begin article-title 85
###xml 94 99 <span type="species:ncbi:9606">human</span>
Functional organization of repeat addition processivity and DNA synthesis determinants in the human telomerase multimer
###end article-title 85
###begin article-title 86
Crystal structure of the essential N-terminal domain of telomerase reverse transcriptase
###end article-title 86
###begin article-title 87
###xml 26 31 <span type="species:ncbi:9606">human</span>
N-terminal domains of the human telomerase catalytic subunit required for enzyme activity in vivo
###end article-title 87
###begin article-title 88
###xml 10 15 <span type="species:ncbi:9606">human</span>
Switching human telomerase on and off with hPOT1 protein in vitro
###end article-title 88
###begin article-title 89
Structures of the PIN domains of SMG6 and SMG5 reveal a nuclease within the mRNA surveillance complex
###end article-title 89
###begin article-title 90
Telomerase: biochemical considerations for enzyme and substrate
###end article-title 90

